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ILLNESS PERCEPTIONS IN CANCER SURVIVORS 
OVERVIEW 
This thesis is submitted in partial fulfilment of the requirements for the degree of Doctorate in 
Clinical Psychology (Clin.Psy.D.) at the University of Birmingham. The thesis consists of 
two volumes. 
 
Volume 1: Research component  
This volume comprises three chapters. The first chapter is a systematic literature review 
evaluating the existing research on the relationship between illness perceptions (also known 
as illness representations) and psychosocial outcomes in female cancer patients. Leventhal’s 
Common Sense model of illness perceptions, also known as the self-regulatory model, is a 
theoretical model that explores how cognitive and emotional factors influence illness coping 
behaviours and a range of health outcomes (e.g. coping, psychological well-being, quality of 
life) (Hagger & Orbell, 2003; Leventhal, Brisette, & Leventhal, 2003).  Psychosocial factors 
including psychological distress, coping, posttraumatic growth, fear of recurrence, quality of 
life, social and emotional support and changes in health practices were found to be related to 
one or more illness perception domains. A pattern of relationships between negative illness 
perceptions and poor psychosocial outcomes was found across studies. Psychological distress 
was the most frequently reported outcome whilst perceived consequences was the illness 
perception domain most commonly associated with psychosocial outcomes. The literature in 
this field however does not currently allow for a clear understanding of the specific 
psychosocial factors associated with each individual domain of the self-regulatory model in 
female cancer patients; future studies are necessary in order to clarify these relationships 
further. This paper has been prepared for submission to the journal Psycho-Oncology. 
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The second chapter is an empirical study that investigates the relationship between illness 
perceptions, resilience and psychological well-being in cancer survivors. It was hypothesised 
that those with a lower resilience and more negative illness perceptions would have a poorer 
quality of life and poorer psychological outcomes. Participants completed measures assessing 
their illness perceptions, psychological resilience, quality of life and psychological well-
being. Results are in line with previous studies, showing that resilience and illness perceptions 
are significantly related to psychological well-being in cancer survivors. Cancer survivors 
may benefit from psychological interventions to address negative illness perceptions and 
increase psychological resilience. Further research is needed to confirm and expand on these 
findings. This paper has been prepared for submission to the journal Psycho-Oncology.  
The third chapter is a public domain briefing document, providing and accessible summary of 
the literature review and empirical paper. 
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Volume 2: Clinical component  
Five Clinical Practice Reports (CPRs) are presented in this volume. The first report details the 
case of a nine year-old girl referred to Child and Adolescent Mental Health Services with 
anxiety and is formulated from cognitive and systemic perspectives. Secondly, a service 
evaluation is presented exploring the views held by facilitators of parenting groups on their 
understanding of the role of, and the services provided by the parenting team who coordinate 
the groups. Thirdly, a single case experimental design is presented, which was used to 
evaluate the effectiveness of cognitive-behavioural therapy with a 49 year-old man with 
severe depression. The fourth report is a case study presented from an acceptance and 
commitment perspective of a woman with depression and a diagnosis of HIV. The fifth report 
is the abstract of an oral presentation of the use of reciprocal imitation training with a two and 
a half year-old girl with features of autism.  
 
All names and identifying features have been changed to maintain confidentiality. 
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ILLNESS PERCEPTIONS AND PSYCHOSOCIAL WELL-BEING IN FEMALE CANCER 
PATIENTS. A SYSTEMATIC REVIEW. 





Objective: Illness perceptions refer to the way in which individuals think about their health 
problems and behave in response to them. This review systematically evaluated literature 
relating to the key psychosocial factors (quality of life, social and emotional support and 
psychological well-being) associated with illness perceptions in female cancer patients. 
Method: A literature search using keywords was conducted with three databases: Medline, 
PsycINFO and EMBASE. Included studies presenting empirical findings focused on adult 
female cancer patients. A quality assessment was carried out for each study. A total of 16 
studies were included in this review.  The IPQ constructs and the psychosocial domains were 
used to organise the data extracted from the papers.  
Results: Psychological distress was the most frequently assessed psychosocial outcome. 
While there is variability, there are indications of robust associations between identity, 
timeline, consequences, causal beliefs, control beliefs and psychological well-being (defined 
as psychological distress, coping and fear of recurrence).  
Conclusions: A pattern of relationships between negative illness perceptions and poor 
psychosocial outcomes is evident across studies. Psychological distress was the construct 
most often measured in the studies and it was also the construct most frequently found to have 
a significant association with illness perceptions; perceived consequences was the illness 
perception most commonly associated with psychosocial outcomes. Little overlap between 
psychosocial factors and illness belief domains across studies made it difficult to generalise 
the findings. Further research is required in order to fully explain the relationship between 
individual illness perceptions and psychosocial outcomes in female cancer patients




Cancer is among the leading causes of morbidity and mortality worldwide with 14 million 
new cancer diagnoses in 2012 and 8.2 million cancer-related deaths the same year (World 
Cancer Report, 2014). The most common cancers in women are breast, colorectum, lung, 
cervix, and stomach cancer (World Cancer Report, 2014). Breast cancer is by far the most 
common cancer in females with more than 464,000 new cases diagnosed in the UK in 2012 
and accounting for almost a third of all female cases in the UK (Cancer Research UK, 2014). 
The next most common cancers in women are lung and bowel, each accounting for similar 
proportions of cases (12% and 11%, respectively) (Cancer Research UK, 2014). Advances in 
detection techniques, improved treatments and an ageing population have led to prevalence 
rates rising (DeSantis, Ma, Bryan & Jemal, 2014) and the rates of cancer survivors increasing 
by ~3% each year (Maddams, Brewster, Gavin, Steward, Elliott, Utley & Møller, 2009).  
A diagnosis of cancer has a significant negative impact on mental health, quality of life 
(QoL), relationships and employment in both men and women (Avis, Crawford & Manuel, 
2005; Burgess, Cornelius, Love, Graham, Richards & Ramirez, 2005; Sanda, Dunn, 
Michalski, Sandler, Northouse, Hembroff & Wei, 2008; Pitceathly & Maguire, 2003; 
Hofman, Ryan, Figueroa-Moseley, Jean-Pierre & Morrow, 2007). Adverse psychological 
consequences are frequently associated with cancer diagnoses and treatment, including 
depression, anxiety, post-traumatic stress disorder and fear of recurrence (McCorkle, Tang, 
Greenwald, Holcombe & Lavery, 2006; Amir & Ramati, 2002; Weitzner et al., 1997; 
Kornblith & Ligibel, 2003; Foster et al., 2009; Payne, Sullivan & Massie, 1996).  
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There are significant gender differences however in how men and women perceive their 
cancer diagnosis due to both social and biological differences, as well as the interaction 
between these factors (Friedman, 2011). From a biological perspective, some types of cancer 
are unique to one or other gender (e.g. gynaecological cancer or prostate cancer) and some 
differ in prevalence between genders. These gender differences can lead men and women to 
respond differently to a cancer diagnosis and women may have different needs compared to 
men coping with similar stressors (Vazquez, Gibson, & Kustra, 2007).  
From a social perspective, social norms and gender roles give rise to different expectations of 
illness from men and women and can have an impact on the interpretation of symptoms and 
the formulation of illness perceptions (Friedman, 2011). For example, gender-biased 
stereotypes could lead to a misattribution of symptoms, different care-seeking behaviours and 
to different rates of diagnosis between male and female patients. Men with breast cancer, for 
example, tend to be diagnosed at an older age compared to women with the same diagnosis 
and tend to receive diagnoses of later-stage disease (Giordano, 2005). Therefore, the process 
of developing illness perceptions cannot be seen in isolation from the social differences in 
gender that are prevalent in society (Friedman, 2011). Another important effect of gender is 
that social constraints may lead to a person not taking appropriate action (even though they 
held illness perceptions that could have led to them taking appropriate action) (Benyamini, 
2009). An example of this is that of women in traditional societies (societies characterised by 
an orientation to the past), for example in rural communities in Mexico, where at times, they 
are prohibited by their husbands from undergoing gynaecological examinations (Givaudan, 
Pick, Poortinga, Fuertes & Gold, 2005).  
Research also suggests that there are sex differences in the process of symptom perception 
(Van Wijk et al., 1997). According to this research health surveys, studies on physical 
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symptom reporting and medical registration of physical complaints show that there are sex 
differences in symptom reporting, with women having the higher rates. According to Van 
Wijk et al. (1997) differences between men and women on these factors originate from early 
socialisation, traditional sex roles, and differences in social position. The authors discuss a 
symptom perception model that brings together factors and processes which are thought to 
affect symptom reporting, such as somatic information, selection of information through 
attention and distraction, attribution of somatic sensations, and the personality factors 
somatisation and negative affectivity (Van Wijk et al., 1997).   
Research focusing on female cancer patients shows that there are a number of adverse 
psychological, medical and economic consequences of cancer survival and these often lead to 
negative psychosocial outcomes (Aziz 2002; Gotay & Muraoka 1998; Ganz 2001). A study 
analysing levels of anxiety and depression after cancer diagnosis showed that women reported 
higher rates of anxiety and depression compared to men, and for some cancer types the 
prevalence was two to three times higher in women (Linden, 2012). This finding was 
consistent with data in the general healthy female population where anxiety and depression 
rates are higher for women as compared to men (Piccinelli and Wilkinson, 2000). These 
differences may reflect a gender difference in willingness to report distress but could also 
reflect a tendency in women to use an emotional approach to coping and chose to express 
their emotions more than men (Goldzweig et al., 2009, Jacobs-Lawson et al., 2010; Linden, 
2012; Stanton et al., 2000). Changes in social relationships have also been reported following 
cancer diagnosis and treatment, with some female survivors reporting fewer interactions with 
friends and relatives (Bloom, Stewart, Chang & Banks, 2004) and others reporting a lack of 
social and emotional support (Wyatt & Friedman 1996). Another significant challenge faced 
by women with cancer is the impact of changes to their body and appearance, which can act 
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as constant reminders of the disease and its treatment (Harcourt & Frith, 2008) and can also 
impact on and lead to changes in relationships. This is particularly challenging in a society in 
which women value their physical appearance and it gives them a significant sense of self-
worth (White, 2000). Physical appearance (e.g. hair loss following cancer treatment) can act 
as a visible indicator of a woman’s disease and therefore it is seen as a confirmation of 
identity as a cancer patient (Harcourt & Frith, 2008; Rosman, 2004). 
In a study by Carelle et al. (2002) patients ranked side effects related to body image (e.g. such 
as hair loss, weight loss, and loss of sexual interest) among the most severe side effects of 
their chemotherapy treatments. However, female patients with cancer placed more emphasis 
on appearance and sexually related side effects than did male patients (Carelle et al., 2002). In 
a study comparing male and female cancer survivors responses relating to their physique and 
perceived sexual appeal, women reported dislikes with their body image more often than men 
(DeFrank et al., 2007). The same study also found that sexual dysfunction was not associated 
with body image for men whilst female body image was strongly associated with sexual 
functioning (DeFrank et al., 2007).  
 Long-term physical health problems and poorer physical and role functioning have been 
associated with poorer QoL outcomes (e.g. poorer emotional health, sexual health and pain) in 
female cancer patients (Casso et al. 2004). QoL has also been found to vary according to 
treatment type (Foster, Wright, Hill, Hopkinson & Roffe, 2009) with more advanced stage of 
cancer associated with poorer QoL (health, socioeconomic, psychological/spiritual 
functioning) in breast cancer survivors (Weitzner, Meyers, Stuebing & Saleeba, 1997).  
Psychosocial interventions have been shown to lead to positive outcomes in the general 
oncology population (Rehse, & Pukrop, 2003; Sheard & Maguire, 1999). These include 
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support groups, individual psychotherapy, imagery, social support, psychoeducation and 
cognitive behavioural therapies (Groarke, Curtis & Kerin, 2013; Manne, Ostroff & Winkel, 
2007). Increasing research in female cancer patients shows that, to support cancer patients’ 
psychosocial well-being it is important to understand patients’ cognitive representations of 
disease and associated coping mechanisms (Cameron, Leventhal & Love, 1998; Millar, 
Purushotham, McLatchie, George & Murray, 2005; Scharloo, Baatenburg, Langeveld, van 
Velzen-Verkaik, Doorn-op den Akker & Kaptein, 2005).  
There are several theoretical models within the field of health psychology that could be 
applied to the understanding of patients’ cognitive representations. One such model is 
Leventhal’s Common Sense model (CSM). This model is of particular interest for a number 
of reasons; it is a useful model for eliciting and understanding patients’ beliefs about their 
cancer since it is structured around key domains including perceptions regarding identity, 
cause, timeline, consequences, cure/control and emotional representations. These are 
important constructs in cancer since it is assumed that individuals represent their condition on 
this set of dimensions (Hagger & Orbell, 2003) and these dimensions have been validated in 
numerous studies and can be regarded as the core components of illness representations 
(Hagger & Orbell, 2003; Heijmans & De Ridder, 1998; Weinman et al., 1996). Additionally, 
since its development over 30 years ago, the CSM has provided health workers and 
researchers with a useful and clear framework for helping to understand the role of cognitive 
factors in response to and in the management of a wide variety of illnesses (Hagger & Orbell, 
2003). A strength of the model is that it conceptualises patients as problem solvers who take 
an active role in the management of their health. The increase in research investigating illness 
perceptions across illnesses has been further facilitated by the development of a tool used to 
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reliably assess illness perceptions: the Illness Perception Questionnaire (IPQ; Weinman, 
Petrie, Moss-Morris, & Horne, 1996).  
Leventhal’s Common Sense model of illness perceptions, also known as the self-regulatory 
model, is a theoretical model that explores how cognitive and emotional factors influence 
illness coping behaviours and a range of health outcomes (e.g. coping, psychological well-
being, quality of life) (Hagger & Orbell, 2003; Leventhal, Brisette, & Leventhal, 2003). 
According to this model, when individuals are faced with a health threat, they create 
representations from prior knowledge and past experiences of their illness (also called illness 
perceptions, cognitive representations or schema), which enable them to make sense of their 
symptoms and guide any coping actions (Hale, Treharne & Kitas, 2007). Illness perceptions 
are seen to guide the decisions people make around developing action plans, managing their 
treatment regimens and influence their coping strategies. These coping strategies in turn have 
an impact on the individual’s illness outcomes and emotional well-being (Leventhal, Halm, 
Horowitz, Leventhal & Ozakinci, 2005). 
Leventhal et al. (1997) described a consistent pattern in the way patients structure their 
perceptions of illness. Firstly there is an identity component, which refers to the label or name 
given to the condition and the statements regarding beliefs about what symptoms arise from 
the condition (Hagger & Orbell, 2003). Research has found that people are often likely to 
interpret diverse symptoms as evidence of the label and identity beliefs have been found to 
influence the process of adjustment (Meyer, Leventhal, & Gunman, 1985). For example, in a 
study looking at adjustment and coping in women with breast cancer, Millar et al. (2005) 
found that the perceived impact of symptoms was a significant predictor of distress both in 
the cross-sectional and prospective analyses. These identity beliefs have been found to 
influence a number of outcomes including decision-making, coping behaviours, health-
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management and early-detection behaviours across physical health populations (Rutter & 
Rutter, 2002; Houldin, Jacobsen  & Lowery, 1996).  
Patients also hold beliefs about the perceived cause of illness; covered by the cause 
component of the model. The causal beliefs may include biological, emotional, psychological 
and/or environmental factors and these may not be completely bio-medically accurate. They 
are based on information gathered from individual experience, conversations with other 
people, the media and health professionals (Hale et al., 2007). Furthermore, illness perception 
components include individuals’ beliefs about the course of the illness (how long the 
condition might last, whether it will be acute or chronic and the time scale of illness 
symptoms); this is referred to as the time-line dimension. More recently a cyclical time-line 
component was also added to the time-line dimension; this refers to beliefs about fluctuations 
in the symptoms and the temporal variability of the illness (this subscale is helpful when 
working with individuals whose illness cannot be adequately captured on a simple 
acute/chronic dimension such as menstrual disorders, skin conditions and some auto-immune 
disorders) (Moss-Morris et al., 2002). 
 The beliefs a person has about the consequences of the illness to their life (physically and 
socially) and the impact on their functioning are known as the consequences dimension. 
Lastly, the curability/controllability dimension refers to the beliefs about whether the 
condition can be cured or kept under control (e.g. beliefs around the efficacy of treatment or 
beliefs around the individual’s role in playing a part in controlling their illness). 

















                                   Figure 1. Common Sense Model of Illness Cognitions (Rozema, Vollink & Lechner, 2009; Hagger & Orbell, 2003)  
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The CSM model is described as the ‘parallel-processing’ model since people are assumed to 
make simultaneous cognitive and emotional representations of their illness (Leventhal, Meyer 
& Nerenz, 1980) and these may be important in leading to emotional outcomes (Moss-Morris, 
Weinman, Petrie, Horne, Cameron & Buick, 2002) (see Figure 1). As people experiencing a 
physical health condition obtain new information about their illness and evaluate their 
attempts to cope with its effects, new illness perceptions are created and develop based upon 
these experiences. Illness perceptions derive from a number of sources, i.e. personal 
experiences, information obtained from others and from health professionals, which integrate 
with existing beliefs and knowledge that people hold, enabling them to make sense of their 
symptoms and guide their behaviours. As new information becomes available, illness 
perceptions may change, may be discarded or adapted, or new illness perceptions may be 
created (Hale et al., 2007). Such beliefs, however, can differ significantly from the medical 
view of an illness (Kaptein et al., 2010). Illness perceptions are associated with coping 
strategies, behaviours and action plans (such as changing dietary content) and outcomes (Hale 
et al., 2007; Hale, Treharne, Macey & Kitas, 2006). 
The increase in research investigating illness perceptions across illnesses was facilitated, in 
part, by the development of a tool used to reliably assess illness perceptions: the Illness 
Perception Questionnaire (IPQ; Weinman, Petrie, Moss-Morris, & Horne, 1996). A revised 
version of the IPQ was later developed with three additional sub-scales (timeline cyclical, 
coherence and emotional representation) and the separation of the cure/control dimension 
into two separate dimensions: treatment control and personal control (IPQ-R; Moss-Morris et 
al., 2002). Emotional representation refers to emotional responses generated by an illness and 
illness coherence refers to whether the patient feels that they understand the illness, or if it 
appears to them as mysterious and incomprehensible (Moss-Morris et al., 2002). More 
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recently a shorter version of the IPQ-R has been developed, the Brief Illness Perception 
Questionnaire (BIPQ), which has good reliability and validity (in asthma, renal and diabetes 
outpatients) (BIPQ; Broadbent, Petrie, Main & Weinman, 2006). 
There is growing evidence illustrating strong relationships between illness perceptions and 
physical and psychological health outcomes (Cameron & Moss-Morris, 2004; Dorrian, 
Dempster & Adair, 1999). Meta-analyses and reviews have been carried out looking at illness 
perceptions across a number of physical health conditions (e.g. Hagger & Orbell, 2003; 
Foxwell et al., 2013; Parfeni et al., 2013). These have illustrated that an individual’s 
knowledge about their symptoms (identity), their belief in the controllability of their illness 
(personal control) and their belief in the appropriateness and effectiveness of the treatment 
(treatment control) are associated with more adaptive outcomes of psychological well-being 
and social functioning. On the other hand, more negative and unhelpful beliefs were related to 
more maladaptive outcomes (e.g. poorer social and role functioning and psychological 
distress) (Hagger & Orbell, 2003; Hampson, 1997; McSharry, Moss-Morris, & Kendrick, 
2011). Furthermore, according to Hagger and Orbell’s (2003) meta-analytic review of patients 
across a number of physical health populations, more positive perceived consequences and a 
weaker illness identity have been associated with poorer adaptive psychological outcomes 
including social, physical and psychological well-being. 
Studies in cancer patients have found that negative illness perceptions predicted worse health-
related quality of life and depression after treatment (Chaboyer, Lee, Wallis, Gillespie & 
Jones, 2010; Traeger, Penedo & Gonzalez 2009). With regards to illness perceptions in the 
female cancer population, Rabin, Leventhal, and Goodin (2004) found that breast cancer 
patients reported increased anxiety, depression and fear of recurrence when they believed that 
their cancer timeline was chronic or cyclical. Additionally, research suggests that illness 
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perceptions are associated with both general distress and quality of life in breast cancer 
patients (Jorgensen, Frederiksen, Boesen, Elsass & Johansen, 2009; Millar et al., 2005; Rabin 
et al., 2004), however there is considerable variation across these studies in terms of the 
illness domains being measured. In addition, specific causal beliefs about cancer (beliefs 
around altered immunity), as well as illness related distress and avoidant coping styles, 
predicted psychosocial support group attendance (Cameron, Booth, Schlatter, Ziginskas, 
Harman & Benson, 2005). 
These relationships between illness perceptions, psychological states and coping have led 
researchers to carry out theoretically guided investigations into the ways in which people 
understand and cope with illness with the aim of developing treatment programmes designed 
to change inaccurate and negative illness perceptions and improved outcomes. Petrie, 
Cameron, Ellis, Buick and Weinman (2002) tested whether a brief psychological hospital-
based intervention designed to change illness perceptions of myocardial infarction would 
result in changes in outcomes; it was found that following the intervention, patients returned 
to work earlier compared to those who had not attended the group and their reported rates of 
symptoms were significantly less frequent. Cognitive behavioural approaches have also been 
used to change illness-related cognitions and have been found to mediate treatment related 
improvements and improve psychological well-being (in patients with irritable bowel 
syndrome and in patients with prostate cancer) (Chilcot & Moss-Morris, 2013; Traeger, 
Penedo, Benedict, Dahn, Lechner, Schneiderman, & Antoni, 2013).  
A number of research studies in female cancer patients over the past two decades have looked 
at the relationship between illness perceptions and factors such as physical and psychological 
well-being, quality of life, psychosocial adjustment and engagement in treatment (Cameron et 
al., 2005; Jorgensen, et al. 2009; Millar et al., 2005; Silva, Moreira & Canavarro, 2012) and 
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researchers are starting to gain an understanding of some of the factors associated with illness 
perceptions within this specific population. Increasingly, studies suggest that women’s illness 
perceptions (Costanzo, Lutgendorf, Bradley, Rose & Anderson, 2005; Gould, Brown & 
Bramwell, 2010), and their coping responses (Costanzo, Lutgendorf, Rothrock & Anderson 
2006; Gould et al., 2010), influence psychological outcomes (Gould et al., 2010).  
Despite the availability of studies that have looked at illness perceptions in male and female 
populations, no previous literature review has explored the relationship between illness 
perceptions and psychosocial factors (psychological distress, coping, posttraumatic growth, 
fear of recurrence, quality of life, social and emotional support and changes in health 
practices) in female cancer patients.  
Given that the process of developing illness perceptions and the actions that are consequently 
taken in response to these perceptions are influenced by biological and social differences 
between men and women (Benyamini, 2009), this review focused on illness perceptions and 
psycho-social well-being in female cancer patients in particular. This review is required in 
order to further our understanding of these individual illness perception domains and their 
relationship with psychosocial outcomes in this population. Additionally, research in this area 
will be helpful in the identification of ‘at-risk’ groups and in the further development of 











Guidelines produced by the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) for the identification of articles for review were used to develop search 
criteria (Moher, Liberati, Tetzlaff, Altman, & The PRISMA Group, 2009).  
Three methods were used to identify relevant studies: a keyword search, a backward search 
and a forward (citation) search (Figure 2). Literature searches were performed using three 
electronic databases: Medline (1946 – September 2014), PsycINFO (1967 – September 2014) 
and EMBASE (1974 – September 2014). The search terms were grouped into cancer terms 
(cancer, oncolog*, neoplasm*) and illness perception terms (illness cognition*, illness 
representation*, illness perception*, illness belief*, self regulat* model, common sense 
model*). Terms relating to cancer were then combined using OR, as were terms relating to 
illness perceptions. The combined cancer and illness perception terms were further combined 
using the AND function. Titles and abstracts of the full list of identified studies were read 
and, if suitable, a full-text copy was retrieved and assessed against inclusion/exclusion 
criteria. Duplicates were excluded. A backward search was then performed, which involved 
hand searching the reference lists of included articles. A forwards (citation) search was then 
conducted. 
Studies were included based on the inclusion/exclusion criteria shown below. Results sections 
were examined and psychosocial factors associated with illness perceptions in female cancer 
patients compiled. This allowed all studies that concerned a certain factor to be grouped 
together and to be considered in relation to each other. 
 




Inclusion and exclusion criteria 
Articles that met the following criteria were included in the review: (1) included female 
participants (age > 18) who had received a diagnosis of any type of cancer, (2) were empirical 
studies, (3) were based on Leventhal’s Self-Regulation or Common Sense model to 
conceptualise illness perceptions, (4) presented information on one or more of the following 
psychosocial outcomes: psychological well-being (psychological distress, coping, 
posttraumatic growth, fear of recurrence), quality of life, social and emotional support or 
changes in health practices, (5) studies involving male participants, if the data from males and 
females could be differentiated. Studies were excluded from the review if they reported data 
on both female and male cancer patients that could not be differentiated; if they were not 
empirical studies (commentaries, dissertation abstracts, books, case studies, conference 
abstracts), and if the studies were not published in English. The articles included in the review 
therefore included females with different cancer diagnoses (breast, cervix, gynaecological and 
lung) and at different stages of their cancer journey (some with non-metastatic cancer and 
receiving curative treatment and some at the palliative stage of care). 

































Exclusion of irrelevant articles 
mainly looking at illness 
perceptions in male as well as 
female cancer populations (in 
which the results could not be 
differentiated), or articles that 
did not look at illness 
perceptions in cancer patients or 
duplicates of other studies or 
reviews or not written in English      
n = 602 
Retrieval of article in full for 
potentially relevant studies             




Exclusion of qualitative studies, 
studies with non relevant 
outcomes (not psychosocial 
outcomes), studies that did not 
use Leventhal’s Self Regulatory 
Model of Illness Perceptions        
n = 20 
Identification of potentially 
relevant studies (title and 
abstract) by searching on 
electronic databases MEDLINE, 
EMBASE, PsycINFO                                        
n = 751 
Studies included in the review    
n = 16 
 





A standard quality checklist of 11 items (Kmet, Lee & Cook, 2004) (Appendix A) was used to 
assess the extent to which each study fulfilled a pre-existing set of criteria. The broad nature 
of the quality assessment allowed a range of methodologies to be assessed. Studies were rated 
according to the method outlined by Crist and Grunfeld (2013). Studies were scored 
depending on whether they met each criterion (Table 1) (yes = 2, partially = 1 and no = 0). If 
a criterion was not applicable, then it was excluded from the score calculation. A ‘total sum’ 
score was calculated by summing the ‘yes’ and ‘partial’ scores. The ‘total possible sum’ was 
calculated as possible responses (excluding n/a responses) multiplied by two. Finally, a 
‘summary score’ was obtained by dividing the ‘total sum’ by the ‘total possible sum’, 
reflecting the overall methodological quality. Studies were categorised as high quality (score 
of 17 or above), moderate quality (11 to 16) or low quality (10 or less) (Crist & Grunfeld, 
2013). 
Analytic approach  
The IPQ constructs of identity, cause, timeline, consequences, control, emotional 
representations and coherence were used to organise the data extracted from the papers. This 
data was additionally organised according to the psychosocial domains of ‘psychological 
wellbeing’, ‘quality of life’, ‘social and emotional support’ and ‘changes in health practices’. 
This information was extracted from the studies by identifying whether the outcome measures 
and results of the studies fitted into these psychosocial categories and was organized as 
presented in Table 4. 





Description of studies included 
From the electronic search 751 potentially relevant articles were identified; of these, 16 
studies fulfilled the inclusion and exclusion criteria (see Figure 2). The majority of the studies 
were classified as high quality, two as moderate quality and none as low quality (Table 1). 
Twelve studies used cross-sectional designs, three prospective designs and one an exploratory 
design using a combination of data from two studies (a randomized controlled trial and a 
descriptive study which were both part of a longitudinal study). Twelve studies focused on 
breast cancer, two on cervical cancer, one on gynaecological cancer (including cervical, 
endometrial, ovarian and vulvar cancers) and one focused on breast, gynaecological (type not 
specified) and lung cancer. Across the studies, five illness perception measures were used; the 
IPQ-R (n = 9), B-IPQ (n =3), IPQ (n =1), a questionnaire developed by the authors based on 
the IPQ (n=2), and one study used only the timeline sub-scale from the IPQ. Total sample size 
across all studies was 2007 (range:  61 to 371). Studies were carried out across eight countries 
(e.g. UK, Denmark, New Zealand, USA, Portugal, India, The Netherlands and Australia). 
Participants were predominantly White females. Eleven studies reported ‘psychological 
distress’ outcomes such as depression and anxiety in relation to one or more of the illness 
perception subscales (Millar et al., 2005; Jorgensen, et al., 2009; Cameron et al., 2005; Silva 
et al., 2012; Awasthi & Mishra, 2006; Awasthi & Mishra, 2010; Henselmans, Sanderman, 
Baas, Smink & Ranchor, 2009; Gould et al., 2010; Rozema et al., 2009; Duric, Butow, 
Sharpe, Boyle, Beith, Wilcken, Heritier, Coates et al., 2007; Mc Corry Dempster, Quinn, 
Hogg, Newell, Moore, Kelly & Kirk, 2013), one study reported ‘coping’ outcomes (Rozema 
et al., 2009), one study reported ‘posttraumatic growth’ outcomes (Silva et al., 2012), two 




studies reported ‘fear of recurrence outcomes’ (Corter, Findlay, Broom, Porter & Petrie, 2013; 
Rabin et al., 2004), three studies reported ‘quality of life’ outcomes (Croom, Hamann, Kehoe, 
Paulk & Wiebe, 2013; Jorgensen et al., 2009; Silva et al., 2012), three studies reported 
‘changes in health practices’ outcomes (Croom et al., 2013; Duric et al., 2007; Costanzo et al., 
2011) and four studies reported ‘social and emotional support’ outcomes (Awasthi et al., 
2006; Awasthi et al., 2010; Iskanarsyah, de Klerk, Suardi, Soemitro, Sadarjoen & Passchier, 
2013; Cameron et al., 2005). These outcomes were categorised according to whether they 
related to the identity, cause, timeline, consequence, control, emotional representation or 
coherence subscales of the IPQ (see Tables 3 and 4). The measures that were used to assess 
psychological well-being, quality of life, social and emotional support and changes in health 
practices are listed in Table 2. 
 




Table 1. Summary of studies 
Authors, date and country Study design Sample size, cancer type (s) Measure of Illness Perceptions Quality 
rating 
Millar et al. (2005), UK Prospective  371, breast  Illness Perception Questionnaire  High 
Jorgensen et al. (2009), Denmark Exploratory  177, breast  Revised Illness Perception Questionnaire High 
Cameron et al. (2005), New Zealand Prospective  110, breast  Revised Illness Perception Questionnaire High 
Costanzo et al. (2011), USA Prospective  79, breast  Revised Illness Perception Questionnaire High 
Silva et al. (2012), Portugal 
 
Cross–sectional 78, breast  Brief Illness Perception Questionnaire (Portuguese version) High 
Awasthi et al. (2006), India Cross–sectional  100, cervix  Illness causation, consequences, controllability beliefs measure and 
outcome brief measure 
Mod 
Awasthi et al. (2010), India Cross–sectional 100, cervix  Illness causation, consequences, controllability beliefs measure and 
outcome brief measure 
Mod 
Henselmans et al. (2009), The Netherlands Cross–sectional 242, breast  Revised Illness Perception Questionnaire High 
Gould et al. (2010), UK Cross–sectional 61, gynaecological  Revised Illness Perception Questionnaire  High 
Rozema et al. (2009), The Netherlands Cross–sectional 119, breast Revised Illness Perception Questionnaire High 
Rabin et al. (2004), USA Cross–sectional 69, breast  Measure to assess perceived timeline of cancer High 
Corter et al. (2013), New Zealand Cross–sectional 153, breast  Brief Illness Perception Questionnaire  High 
Duric et al. (2007), Australia Cross–sectional  83, breast  Revised Illness Perception Questionnaire  High 
Mc Corry et al. (2013), UK Cross–sectional 90, breast  Revised Illness Perception Questionnaire  High 
Iskanarsyah et al. (2013), The Netherlands Cross–sectional 70, breast  Brief Illness Perception Questionnaire High 
Croom et al. (2013), USA Cross–sectional 105, breast, gynaecological, 
lung 
Revised Illness Perception Questionnaire  High 




Table 2. Assessment measures used in each study  




General Health Questionnaire (GHQ) 
 
Profile of Mood States (POMS – SF) 
 
 








Center for Epidemiologic Studies Depression (CES-D) Scale 
 
 
Cancer Worries Scale 
 
RAND-36 (Dutch translation) 
 
Impact of Events (IOE) 
 
Revised Impact of Events Scale (RIES) 
 
Coping 
Mental Adjustment to Cancer Scale (MAC) 
 




Utrecht Coping Questionnaire (UCL) 
 
Revised Life Orientation Test (LOTr) 
 
Cancer Coping Questionnaire  
 
Posttraumatic growth 
Posttraumatic Growth Inventory (Portuguese version) 
 
Fear of Recurrence 
A Fear of Reccurence Scale based on a scale assessing fear of ovarian 
cancer 
 
Worry about Cancer Scale 
 
 
Millar et al. (2005) 
 
Jorgensen et al. (2009); Gould et al. (2010) 
 
 
Silva et al. (2011); Rabin et al. (2004); Corter 
et al. (2012); Duric et al. (2007); McCorry et 
al. (2013) 
 
Cameron et al. (2005); Henselmans et al. 
(2010); Duric et al. (2007) 
 
 
Cameron et al. (2005); Henselmans et al. 
(2010) 
 
Henselmans et al. (2010) 
 
Rozema et al. (2009) 
 
Duric et al. (2007) 
 
Cameron et al. (2005) 
 
 
Millar et al. (2005) 
 
Awasthi et al.  (2006) 
 
Gould et al. (2010) 
 
Rozema et al. (2009) 
 
Duric et al. (2007) 
 
McCorry et al. (2013) 
 
 
Silva et al. (2011) 
 
 
Rabin et al. (2004) 
 
 
Corter et al. (2012) 




QoL-BREF (WHOQOL-Bref) (Portuguese version) 
 
The Functional Assessment of Cancer Therapy General scale (FACT-G) 
 
Jorgensen et al. (2009) 
 
Iskandarsyah et al. (2013) 
 
Silva et al. (2011) 
 




Social Network Measure 
 
Social Support Measure 
 
Sarason’s Social Support Questionnaire (SSQ) 
 
Social Support Behaviours Scale 
 
Cameron et al. (2005) 
 
Awasthi et al. (2006); Awasthi et al. (2010) 
 
Duric et al. (2007) 
 
Cameron et al. (2005) 
Changes in 
health 
practices   
Self –reported changes following cancer diagnosis  Costanzo et al. (2011) 
 




Psychosocial factors associated with each dimension of illness perceptions are discussed, with 
the aim of ascertaining the extent to which psychosocial factors (e.g. psychological distress, 
coping, posttraumatic growth, fear of recurrence, quality of life, changes in health practices 
and social and emotional support) are associated with illness perceptions in female cancer 
patients (see Table 3). A summary of results is presented in Table 4.   









Table 3. Main factors examined in relation to illness perceptions 
 





Milllar et al. 
(2005); Rozema 
et al. (2009); 
Duric et al. 
(2007); 
McCorry et al. 
(2013) 
 
Jorgensen et al. 
(2009); Cameron 
et al. (2005); 
Awasthi et al. 
(2010); McCorry 
et al. (2013) 
Milllar et al. (2005); 
Gould et al. (2010); 
Rabin et al. (2004); 
McCorry et al. (2013) 
Silva et al. (2011); 
Awasthi et al. (2006); 
Gould et al. (2010); 
Rozema et al. (2009); 
McCorry et al. (2013) 
Henselmans et al. (2010); 
Gould et al. (2010); 
Rozema et al. (2009); 
McCorry et al. (2013) 
Rozema et al. 
(2009) 
Gould et al. 
(2010); 
McCorry et al. 
(2013) 
Coping  Rozema et al. 
(2009) 
 
Rozema et al. (2009) 
 
 Rozema et al. (2009) 
 







   Silva et al. (2011) 
 
   
Fear of 
Recurrence 
Corter et al. 
(2012) 
Corter et al. 
(2012) 
Rabin et al. (2004); 
Corter et al. (2012) 
Corter et al. (2012) Corter et al. (2012)   
Quality of Life Croom et al. 
(2013)  
  Jorgensen et al. (2009); 
Silva et al. (2013) 




 Awasthi et al. 
(2010); Cameron 
et al. (2005); 
 
 Awasthi et al. (2006); 
Awasthi et al. (2010) 
 
Awasthi et al. (2010); 
Iskanarsyah et al. (2013) 






Duric et al. 
(2007) 
Costanzo et al. 
(2011) 
Costanzo et al. (2011) Costanzo et al. (2011); 
Duric et al. (2007); 
Croom et al. (2013) 
Costanzo et al. (2011)  Croom et al. 
(2013) 
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Table 4. Summary of results for each study presented according to illness perception domains 








was a predictor of 
distress at 3, 6 and 
12 months 
following breast 
surgery (3 months 
β=0.67**; 6 
months β= 0.83**; 
12 months 
β=0.44*) 
Cause as a predictor of 
psychological distress 
was not assessed 
Psychological 
distress: Timeline 
was a predictor of 
distress at 6 and 12 
months following 
breast surgery (6 
months β=-0.90*; 
12 months β= -
0.76*) (i.e. the 
shorter the 
perceived timeline 
of the illness the 
greater the 
distress).  
Consequences as a 
predictor of 
psychological distress 




Control  as a predictor 
of psychological 
distress was not 
assessed 
Not assessed Not 
assessed 
Jorgensen 
et al. (2009) 
Identity was not 
reported as a 
significant factor 
explaining variance 
in Quality of Life 
or Distress. 
Psychological distress: 
Causal beliefs about stress or 
worry explain 22% of variance 
in general distress (F = 4.57*). 
Higher levels of general 
distress associated with a 
stronger belief that stress or 
worry caused the illness (β = 
4.11) 
Timeline was not 
reported as a 
significant factor 
explaining variance 
in Quality of Life 
or Distress. 
Quality of life: 
Higher quality of life 
was associated with a 
perception of less 
severe consequences 
(β = -1.37)  
Quality of life: 
Higher quality of life 
was associated with a 
perception of higher 
treatment control 
beliefs (β = 1.41) – no 
longer significant 
once controlled for 
demographic 
variables 
Not assessed Not 
assessed 
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Table 4. Continued 









Psychological distress: Causal beliefs about 
altered immunity and stress positively 
correlated (r = .32*) 
Social and emotional support: Altered 
immunity causal beliefs and distress were 
associated with a higher propensity to 
participate in a support group (β = .10*). Stress 




Not assessed Social and 
emotional 
support:  control 












Changes in health practices: Causal beliefs 
linked to diet were associated with increase in 
consumption of fruits and vegetables (Wald 
χ²(1) = 5.10*) and decreased fat intake (Wald 
χ²(1) = 5.84*).  
Causal beliefs linked to lack of exercise were 
associated with increased physical activity 
(Wald χ²(1) = 3.90*) by three months post-
treatment. Causal beliefs about cancer linked to 
stress or worry were associated with avoidance 
of stressful situations at three weeks (Wald 
χ²(1) = 3.12*) and three months post-treatment 
(Wald χ²(1) = 3.12*). There were no significant 
relationships between attributing cancer to 












Changes in health practices: 
Women who perceived more 
severe consequences of their 
cancer at 3 weeks post-
treatment were more likely to 
report increasing the frequency 
with which they avoided stress 
by three months post-treatment 
(Wald χ²(1) = 441*). 
Perceptions of disease 
consequences did not 
significantly predict changes in 
fat consumption, physical 
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Not assessed Not assessed Psychological distress: Negative perceptions 
of consequences significantly associated with 
higher emotional distress (depression: r = 
.43**; anxiety: r = .49**). 
Quality of Life: 
Negative perception of consequences 
significantly associated with impaired physical 
and psychological QoL (r = -.42** and r = -
.32* respectively). 
Posttraumatic growth: PTG moderated the 
relationships between negative perceptions of 
the consequences of breast cancer and quality 
of life, acting as a stress-buffering mechanism. 
Among women who perceived breast cancer as 
having a more negative impact on their lives, 
higher PTG buffered this negative perceived 
impact on psychological and social quality of 
life (p<0.01) and also on depression (p<0.06). 
This effect was not found for physical QOL 
and anxiety.  













Not assessed Social and emotional support: Emotional, 
informational, social and practical support 
negatively correlated with consequences 
indicating that greater the level of social 
support, the consequences of illness were 
perceived to be less severe. 
Social and emotional support: 
Patients who scored higher on the social 
support measure held stronger beliefs in 
“self” and “doctor” for illness control 
than those who scored lower on the 
social support measure. Differences 
between these groups were significant 
with respect to self (t = 3.66**) and 
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negatively correlated with 
emotional, informational, 
social companionship and 
practical support (i.e. 
women who received less 
support believed more 




Social and emotional support: 
Practical support, doctor-control and 
supernatural control accounted for 
approximately 49% of the variance in 
score on the interpersonal 
consequences measure (F= 30.92**). 
Practical support accounted for 
approximately 40% of the variance (F= 
65.14**) in scores. 
Overall support (β=-.44), “doctor” 
control (β=-0.27) and supernatural 
causes (β= .17) explained 
approximately 41% of the variance in 
scores on psychological consequences.  
Social and emotional support: “Self” 
control negatively correlated with 
informational and social companionship 
support and positively with practical 
support. “Doctor” control was positively 
correlated with emotional, informational, 









ans et al. 
(2009) 
Not assessed Not assessed Not 
assessed 
Not assessed Psychological distress: women with a 
strong sense of personal control over 
events and situations in life reported less 
anxiety (β=-.19*) two months after the 
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Not assessed Not assessed Psychological distress: 
Denial and disengagement 
coping mediate paths 
between perceptions of a 
cyclical timeline and higher 
POMS Total scores (β= 
.30*). The reverse mediation 
path, from POMS to cyclical 
timeline was not significant 
(POMS to denial/dis.  β= .45, 
p<0.01, denial/dis. to cyclical 






POMS total (r = 
.42**) (where the 
greater the perceived 
consequences, the 





with POMS total (r 
= -.30*) and 
treatment control 
correlated with 
POMS total (r = -
.31*) 
Not assessed Psychological distress: Denial 
and disengagement coping 
mediate paths between 
perceptions of coherence and 
higher POMS Total scores (β= 
-.45**).  The reverse 
mediation path, from POMS to 
coherence was not significant 
(POMS to denial/dis.  β= .45, 
p<0.01, denial/dis. to cyclical 








with mental health (r = 
-.428*) 
Coping: Identity 
related to cognitive and 
behavioural avoidance 
as a coping strategy (r 
= .195* and r = .205* 
respectively). Identity 
did not significantly 
explain any variance in 
the scores of problem-
focused coping.  
Coping: 
Psychological 
cause related to 
behavioural 
avoidance as a 
coping strategy 
(r = .212*). 
Psychological 






(β = -.30**). 
   
Coping: Timeline correlated 
negatively to cognitive and 
behavioural avoidance as a 
coping strategy (r = -.222** 
and r = -.335** respectively).  
Timeline did not significantly 
explain any variance in the 




correlated negatively with 





explain any variance 
















control showed a 
positive correlation 
with mental health (r 
= .265*) as did 
treatment control (r 
= .371*). Treatment  
control was also an 
important explaining 
variable of mental 
health (β = -.22*) 
Coping: personal 









mental health (r = -
.469*) and is an 
explaining variable 
of mental health (β 
= -.32**). Emotional 
representation (β = 
.23*) significantly 
explained 8.4% of 
the variance in 
scores of venting 
emotions (F = 
6.64)* 
Not assessed 
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Not assessed Not assessed Psychological distress: 
Patients reported more 
anxiety (F=8.18**) and 
depression ( F=8.37**) if 
they believed that their 
cancer timeline was 
chronic or cyclical.  
Fear of recurrence: 
Patients reported higher 
fear of recurrence 
(F=9.69**) if they 
believed that their cancer 
timeline was chronic or 
cyclical. 
 










breast cancer) are 
significantly 
related to fear of 
recurrence (β = 
.19*) 
Fear of recurrence: 
Perceived stress as 
cause of cancer 
associated with higher 
fear of recurrence 
(mean difference 
between groups = -
2.7*). Lower fear of 
recurrence in women 
who reported not 
knowing the cause of 
their cancer (mean 
difference between 
groups = 4**). 
Fear of recurrence: 
Longer timelines for the 
experience of breast 
cancer were significantly 
associated with fear of 
recurrence (β = .23*) 
Fear of recurrence: 
Higher fear of 
recurrence associated 
with beliefs in higher 
consequences of breast 
cancer (r = .59**) 
Fear of recurrence: 
Lower beliefs about 
treatment control were 
significantly associated 
with fear of recurrence 
(β = -.24**). Beliefs 
about personal control 
over cancer recurrence 
were not associated with 





















coherence (r = 
-.27**) 
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Duric et al. 
(2007) 
Changes in health practices: Identity was the strongest psychosocial 
predictor associated with judging smaller benefits sufficient to make 
adjuvant chemotherapy worthwhile (p = 0.01).  




















Lower scores for 
perceived 
consequences of 
early breast cancer 




to make adjuvant 
chemotherapy 
worthwhile.  




























Psychological distress:   
Cluster 1 (women with cognitions that the illness has a more chronic and 
cyclical timeline, more severe consequences, more symptoms and have 
lower personal and treatment control and a less coherent understanding 
of the illness. Also includes women who endorse causal attributions more 
strongly, having greater perceptions of emotional, behavioural and 
externalized causes) women had higher levels of anxiety and depression 
compared to women in cluster 2 both at diagnosis (β = .418** and β = 
.405* respectively) and six months post diagnosis (β = -.25** and β = -
.36* respectively).  The clusters were derived by conducting a two-stage 
cluster analysis and Ward’s clustering method was used to identify the 
number of clusters. A K-mean analysis was then conducted using the 
number of clusters and the centroids identified by Ward’s method.  
Cluster 2 included women with cognitions that the illness has a less 
chronic and cyclical timeline, less severe consequences, less symptoms 
and have greater personal and treatment control and a more coherent 
understanding of the illness. Also includes women who endorse causal 
attributions less strongly, having weaker perceptions of emotional, 
behavioural and externalized causes) 
Psychological 
distress: Cluster 1 
women had higher 
levels of anxiety and 
depression 
compared to women 
in cluster 2 both at 
diagnosis (β = -
.418** and β = -
.405* respectively) 
and six months post 
diagnosis (β = -











cluster 2 both at 
diagnosis (β = -
.418** and β = -
.405* 
respectively) 
and six months 
post diagnosis 
(β = -.25** and 
β = -.36* 
respectively). 
Psychological 
distress: Cluster 1 
women had higher 
levels of anxiety 
and depression 
compared to 
women in cluster 
2 both at 
diagnosis (β = -
.418** and β = -
.405* 
respectively) and 
six months post 
diagnosis (β = -











cluster 2 both at 
diagnosis (β = -
.418** and β = -
.405* 
respectively)  
and six months 
post diagnosis 
(β = -.25** and 




1 women had 




women in cluster 
2 both at 
diagnosis (β = -
.418** and β = -
.405* 
respectively) and 
six months post 
diagnosis (β = -
.25** and β = -
.36* 
respectively). 
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yah et al. 
(2013) 
Social and emotional 
support: Satisfaction 
with type and timing of 
information provided 
did not explain a 
significant amount of 








type and timing of 
information 
provided did not 
explain a significant 
amount of variance 
in ‘timeline’ illness 
perceptions. 
Social and emotional 
support: Patients who 
were satisfied with type 
and timing of information 
provided had stronger 
beliefs in personal control 
over their illness (β = -
.30*). 
Social and emotional 
support: Patients 
who were satisfied 
with type and timing 
of information 
provided had stronger 
beliefs in personal 
control over their 
illness (β = -.30*).  
Social and 
emotional support: 
Satisfaction with the 




of the variance of 
emotional 
representations (β = 
-.27*).   
Social and emotional 
support: Satisfaction 
with the amount and 
content of information 
explained a significant 
amount of the variance 
in coherence (β = -




Quality of life: 
Experiencing more 
cancer related symptoms 
(t = -6.23**) and 
perceiving the cancer as 
central to one’s identity 
(t = -3.03*) was 
predictive of poorer 




Changes in health 
practices: 
Greater beliefs 
about the chronicity 
of the timeline were 
significantly 
associated with a 
greater number of 
advanced illness 
behaviours (r= 
.30**).  Quality of 
life: Greater beliefs 
in the timeline being 
cyclical were 
significantly 
associated with a 
poorer quality of 
life (r= -.37**).  
 
 
Changes in health 
practices: Participants 
who reported completing 
a higher frequency of 
advanced illness 
behaviours (e.g. 
discussing cancer and/or 
their future with 
important people or 
completing an advance 
directive) perceived their 
cancer as having more 
severe consequences (t = 
3.19*).  
 





treatment control and 
quality of life. 
Changes in health 





treatment control and 
advanced illness 
behaviours.  
Not assessed Changes in health 
practices: Participants 
who reported 
completing a higher 
frequency of advanced 
illness behaviours (e.g. 
discussing cancer 
and/or their future with 
important people or 
completing an advance 
directive) perceived 
their cancer as more 
understandable (i.e. 
illness coherence; t 
=2.49*) 




 Evidence for an association between perceived identity (symptoms that the individual 
believes are associated to the illness) psychosocial factors in female cancer patients is limited. 
Six studies included in this review measured perceived identity in relation to psychosocial 
outcomes (Corter et al., 2013; Croom et al., 2013; Duric et al., 2007; Mc Corry et al., 2013; 
Millar et al., 2005; Rozema, Völlink & Lechner, 2009). 
Significant negative relationships between identity and psychological well-being were found 
in two studies. Millar et al. (2005) found that reporting a greater number of symptoms 
associated with cancer (i.e. identity) was a predictor of distress at three, six and twelve 
months following breast surgery.  Furthermore, Rozema et al. (2009) found that identity 
correlated negatively with mental health outcomes as measured on the RAND-36. The same 
study also found identity to be related to cognitive and behavioural avoidance as a coping 
strategy. One study reported that more cancer-related symptoms are significantly related to 
fear of recurrence (Corter et al., 2013).  
Only one study explored the association between quality of life and identity (Croom et al., 
2013) reporting that experiencing more cancer-related symptoms and perceiving the cancer as 
central to one’s identity was predictive of poorer quality of life. 
Illness identity was found to be associated with changes in health practices in one study; 
higher identity scores (i.e. attributed common, non-specific somatic symptoms to their breast 
cancer diagnosis or adjuvant chemotherapy) were associated with perceived larger benefits 
necessary to make adjuvant chemotherapy worthwhile. (Duric et al., 2007) These findings 
suggest that patients’ preferences for treatment are formed by an integration of factors, 
including individual beliefs about the illness (identity).  
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Timeline (chronicity and cyclical)  
Timeline includes two components: chronic timeline and cyclical timeline. Chronic timeline 
refers to beliefs about the relative chronicity of the illness whilst cyclical timeline refers to 
beliefs about fluctuations in the symptoms and the temporal variability of the illness (this 
subscale is particularly useful when working with patients whose illness cannot be adequately 
captured on a simple acute/chronic dimension such as skin cancers where the condition could 
be experienced as a stable disease or could be experienced as a timely variation of disease 
severity). 
Seven studies included in this review measured timeline beliefs (Corter et al. 2013; Croom et 
al. 2013; Gould et al., 2010; Mc Corry et al., 2013; Millar et al., 2005; Rabin et al. 2004; 
Rozema et al., 2009). All of these studies explored the relationship between timeline beliefs 
and psychological well-being. Millar et al. (2005) identified that the shorter perceived 
timeline of the illness, the greater the distress at 6 and 12 months following breast surgery, 
which might imply pessimism about survival especially in the first 12 months following 
treatment. Additionally, acute/chronic timeline was found to correlate with mental health 
outcomes (Rozema et al., 2009). Greater beliefs about the chronicity of the timeline were 
found to be significantly associated with a greater number of advanced illness behaviours 
(e.g. participation in cancer-specific activities, preparation for medical decision making, and 
end of life planning) and greater beliefs in the timeline being cyclical were significantly 
associated with a poorer quality of life (Croom et al. 2013). Furthermore, patients reported 
more anxiety and depression if they believed that their cancer timeline was chronic or cyclical 
(Rabin et al., 2004) and perceptions of a cyclical timeline were related to higher scores on a 
measure of mood disturbance (Gould et al., 2010).  
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Associations between timeline perceptions and fear of recurrence were explored in two 
studies. Patients reported a greater fear of recurrence if they believed that their cancer 
timeline was chronic or cyclical (Rabin et al., 2004) and if they perceived the timelines for the 
experience of breast cancer to be longer (Corter et al., 2013).  
Perceptions of a chronic timeline had a strong negative correlation with cognitive and 
behavioural avoidance as a coping strategy in women with breast cancer (Rozema et al., 
2009). Denial and disengagement coping strategies were found to mediate paths between 
perceptions of a cyclical timeline and higher mood disturbance scores in women recently 
diagnosed with gynaecological cancer (with positive associations between the three variables 
in the mediation path) (Gould et al., 2010).  
Consequences 
Twelve studies included a measure of patients’ perceptions about consequences of the illness, 
although the methods used to assess this dimension varied across studies (Awasthi et al., 
2006; Awasthi et al., 2010; Corter et al. 2013; Costanzo et al., 2011; Croom et al. 2013; Duric 
et al., 2007; Gould et al., 2010; Jorgensen et al., 2009; Mc Corry et al., 2013; Rozema et al., 
2009; Silva et al., 2012). 
Perceptions about consequences in relation to psychological distress were investigated in 
three studies. Silva et al. (2012) found that negative perceptions of consequences were 
significantly associated with higher emotional distress (specifically, depression and anxiety). 
In addition, Gould et al. (2010) found that the greater the perceived consequences of cancer, 
the greater the score on a measure of mood disturbance in gynaecological cancer patients; and 
Rozema el al. (2009) identified a significant negative correlation between illness perception 
consequences and mental health outcome measures. 
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Silva et al. (2012) explored the relationship between posttraumatic growth and perceived 
illness consequences in women with breast cancer. They found that posttraumatic growth 
moderated the relationships between negative perceptions of the consequences of breast 
cancer and quality of life, acting as a stress-buffering mechanism. Among women who 
perceived breast cancer as having more negative consequences, higher posttraumatic growth 
buffered this negative perceived impact on psychological and social quality of life (p<0.01) 
and also on depression (p<0.06). This effect was not found for physical QOL and anxiety.  
The relationship between fear of recurrence and consequences of breast cancer was explored 
by only one study; it was reported that beliefs in more severe consequences of breast cancer 
are associated with a greater fear of recurrence (Corter et al., 2013). 
Perceptions about consequences of cancer were explored in relation to quality of life (in two 
studies) identifying that higher scores on quality of life were associated with a perception of 
less severe consequences in breast cancer patients (Jorgensen et al., 2009). In addition, Silva 
et al.’s (2012) study identified a significant association between negative perceptions of 
consequences and impaired physical and psychological quality of life in breast cancer 
patients.  
Relationships between illness perception consequences and changes in health practices were 
found across three studies. Costanzo et al. (2011) found that women who perceived more 
severe consequences of their breast cancer at three weeks post-treatment were more likely to 
report increasing the frequency with which they avoided stress by three months post-
treatment. Furthermore, in a study aimed at exploring women’s preferences with regards to 
receiving adjuvant chemotherapy treatment in breast cancer, the authors identified that lower 
scores for perceived consequences of early breast cancer were associated with judging smaller 
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benefits sufficient to make adjuvant chemotherapy worthwhile (Duric et al., 2007). 
Additionally, Croom et al.’s (2013) study showed that participants who reported completing a 
higher frequency of advanced illness behaviours (e.g. participation in cancer-specific 
activities, preparation for medical decision making, and end of life planning) perceived their 
cancer as having more severe consequences. 
Two studies carried out in India explored social and emotional support in relation to 
perceptions about the consequences of cancer in a sample of women with a diagnosis of 
cancer of the cervix. A greater level of social support was related to less severe perceived 
consequences (Awasthi et al., 2006). Exploration of inter-relationships between illness 
perceptions highlighted that practical support as well as doctor-control and supernatural 
causes accounted for approximately 49% of the variance in score on the interpersonal 
consequences measure. Practical support accounted for approximately 40% of the variance in 
scores. Overall support, “doctor” control and supernatural causes explained approximately 
41% of the variance in scores on psychological consequences (Awasthi et al., 2010). It may 
be important however to acknowledge that these studies included cervix cancer patients 
recruited from urban and rural areas in India and the sample included educated and 
uneducated participants. The generalisability of the findings may therefore be limited by 
factors such as education and location  associated with the sample. 
Cause 
Causal illness perceptions can be categorised into four main groups: psychological 
attributions (e.g., stress or worry), risk factor attributions (e.g., hereditary factors), immunity 
attributions (e.g., a germ or a virus) and chance attributions (e.g., chance or bad luck) (Moss-
Morris et al., 2002). 
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Seven studies included in this review explored causal illness perceptions, although the 
methods used to assess this dimension varied across studies (Awasthi et al., 2010; Cameron et 
al., 2005; Corter et al., 2013; Costanzo et al., 2011; Jorgensen et al., 2009; Mc Corry et al., 
2013; Rozema et al. 2009). 
The relationship between causal beliefs and psychological well-being was explored in six 
studies. Jorgensen et al. (2009) found that causal beliefs of stress or worry explained 22% of 
variance in general distress whereby higher levels of general distress were associated with a 
stronger belief that stress or worry caused the illness. Furthermore, Cameron et al., (2005) 
found that causal beliefs of altered immunity and stress positively correlated with each other. 
Perceived stress as a cause of cancer was also associated with higher fear of recurrence whilst 
a lower fear of recurrence was expressed in women who reported not knowing the cause of 
their cancer (Corter et al., 2013). 
A study exploring coping behaviours in relation to causal beliefs found that psychological 
beliefs about cause were significantly related to behavioural avoidance as a coping strategy 
(Rozema et al. 2009) although these results are not discussed in depth in the paper.  
The relationship between social and emotional support and causal beliefs of cancer was 
investigated in two studies. Cameron et al. (2005) identified that altered immunity causal 
beliefs and illness distress were associated with a higher propensity to participate in a support 
group. Additionally, Awasthi et al. (2010) found that beliefs about individual, psychosocial 
and supernatural causes negatively correlated with emotional, informational, social 
companionship and practical support (i.e. women who received less support believed more 
strongly in these causes of cancer). 
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Costanzo et al.’s (2011) study was the only one to look at causal beliefs of cancer in relation 
to changes in health practices. Causal beliefs linked to diet were associated with an increase in 
consumption of fruits and vegetables and decreased fat intake. Causal beliefs linked to lack of 
exercise were associated with increased physical activity. Causal beliefs linked to stress or 
worry were associated with avoidance of stressful situations at three weeks and three months 
post-treatment.  
Control 
The IPQ includes a single dimension of control/cure whilst the IPQ-R distinguishes between 
the belief in one’s own ability to control illness (personal control) and the belief in the 
efficacy of the treatment (treatment control). 
Six studies included in this review measured perceived control in relation to psychosocial 
factors (Awasthi et al., 2006; Awasthi et al., 2010; Corter et al. 2013; Costanzo et al., 2011; 
Gould et al., 2010; Hanselmans et al., 2009; Jorgensen et al., 2009; Rozema et al., 2009). 
Psychological well-being outcomes were explored in relation to perceived control in five 
studies. Hanselmans et al. (2009) found that women with a strong sense of personal control 
over life reported less anxiety two months after the end of treatment for breast cancer, 
controlling for baseline. In addition, Gould et al. (2010) found that personal control and 
treatment control correlated with mood disturbance (the greater the perceptions of control, the 
lower the scores on the mood disturbance scale). Furthermore, Rozema et al. (2009) found 
that greater treatment control was positively associated with better mental well-being and was 
also an important variable in explaining mental health outcomes. Greater personal control was 
also found to have a significant positive relationship with problem-focused coping (Rozema et 
al., 2009). A study that looked at the relationship between treatment control and fear of 
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recurrence found that lower beliefs about treatment control were significantly associated with 
fear of recurrence (Corter et al., 2013).  
Jorgensen et al.’s (2009) study was the only one to look at the relationship between control 
beliefs and quality of life; higher quality of life was found to be associated with a perception 
of greater treatment control beliefs. These results are no longer significant however, once 
controlled for demographic variables. 
The relationship between control perceptions and social and emotional support was looked at 
in two studies; Awasthi et al. (2006) identified that patients who scored higher on the social 
support measure held stronger beliefs in “self” and “doctor” for illness control than those who 
scored lower on the social support measure. Differences between these groups were 
significant with respect to self and doctor. Greater “self” control correlated with less 
informational and social companionship support and positively correlated with practical 
support. “Doctor” control was positively correlated with emotional, informational, social 
companionship and practical support (Awasthi et al., 2010).  
Emotional representations 
Emotional representations relate to patients’ emotional responses to their illness. Only three 
studies in this review explored the relationship between emotional representations and 
psychosocial outcomes (Corter et al., 2013; Rozema et al., 2009; Iskanarsyah et al., 2013). 
Two studies looked at emotional representations in relation to psychological well-being. 
Rozema et al. (2009) found that experiencing breast cancer as an illness with major emotional 
consequences was related to a lower use of problem-focused coping. Furthermore, the study 
showed that a greater score on the emotional representations subscale only had a significant 
ILLNESS PERCEPTIONS IN CANCER SURVIVORS 
40 
 
positive correlation with the emotion-focused coping strategy of “venting”  (and not with the 
other emotion focused coping strategies e.g. behavioural avoidant coping, seeking social 
support, and cognitive avoidant coping). Emotional representations significantly explained 
8.4% of the scores of venting emotions. Negative emotional consequences of cancer were 
significantly associated with negative mental health outcomes. Additionally, one study looked 
at the association between emotional representations in relation to fear of recurrence. Corter et 
al. (2013) found that negative emotions associated with the diagnosis were significantly 
associated with fear of recurrence. 
Illness coherence 
The coherence subscale of the IPQ-R has the function of assessing the extent to which a 
patient feels that they understand their illness, or if it appears mysterious or incomprehensible.  
Only five studies in this review explored the relationship between illness coherence and 
psychosocial outcomes (Corter et al., 2013; Croom et al. 2013; Gould et al., 2010; Mc Corry 
et al., 2013; Iskanarsyah et al., 2013). 
Two studies were interested in psychological well-being outcomes in relation to illness 
perceptions; Gould et al. (2010) found that denial and disengagement coping styles mediate 
paths between perceptions of low coherence and higher mood disturbance. Additionally, 
Corter et al. (2013) identified that higher fear of recurrence is associated with lower 
coherence. 
Croom et al. (2013) found that participants who reported completing a higher frequency of 
advanced illness behaviours (e.g. participation in cancer-specific activities, preparation for 
medical decision making, and end of life planning) perceived their cancer as more 
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understandable. In addition to this, Iskanarsyah et al. (2013) found that patients who were 
satisfied with the type and timing of information provided to them reported that they felt they 
had a better understanding of their illness (greater illness coherence). 
In addition to the above studies, Mc Corry et al. (2013) employed cluster analysis to 
investigate the associations between psychological distress and illness perceptions in female 
breast cancer patients. Cluster 1 included women with cognitions that the illness had a more 
chronic and cyclical timeline, more severe consequences, more symptoms and had lower 
personal and treatment control and a less coherent understanding of the illness. Cluster 1 also 
included women who endorsed causal attributions more strongly, having greater perceptions 
of emotional, behavioural and externalized causes. Cluster analysis revealed that women in 
cluster 1 had higher levels of anxiety and depression compared to women in cluster 2 (cluster 
2 included women with cognitions that the illness has a less chronic and cyclical timeline, less 
severe consequences, less symptoms and have greater personal and treatment control and a 
more coherent understanding of the illness. Also includes women who endorse causal 
attributions less strongly, having weaker perceptions of emotional, behavioural and 









The aim of this review was that of exploring the relationship between illness perceptions and 
psychosocial factors in female cancer patients.  Gender differences in how men and women 
perceive their illness lead to different and unique needs of women compared to men coping 
with similar stressors (Vazquez, Gibson, & Kustra, 2007). Furthermore, the process of 
developing illness perceptions cannot be seen in isolation from the social differences in 
gender that are so prevalent in our society (Friedman, 2011). As far as we know, no previous 
literature review has explored these relationships. A thorough search and data extraction 
strategy was used, followed by a quality assessment for each paper.  
A pattern of relationships between negative illness perceptions and poor psychosocial 
outcomes was evident across studies (Millar et al. 2005; Jorgensen et al., 2009; Cameron et 
al., 2005; Silva et al. 2012; Henselmans et al. 2009; Gould et al. 2010; Rozema et al., 2009; 
Rabin et al. 2004; Corter et al., 2013; Mc Corry et al., 2013; Croom et al., 2013).  
Psychological distress was the construct most often measured in the studies and it was also 
the construct most frequently significantly associated with illness perceptions (Cameron et al., 
2005; Gould et al. 2010; Henselmans et al. 2009; Jorgensen et al., 2009; Mc Corry et al., 
2013; Millar et al. 2005; Rozema et al., 2009; Silva et al. 2012).  
Psychological distress was found to be associated with the full range of illness perceptions. 
Negative identity and timeline perceptions were predictive of distress in a longitudinal study 
(Millar et al., 2005) and negative perceptions of consequences were associated with greater 
emotional distress (Silva et al., 2012, Gould et al., 2010; Rozema et al., 2009).  Higher levels 
of distress were also associated with stronger beliefs in stress or worry as cause of the cancer 
(Jorgensen et al., 2009; Cameron et al., 2006). The association between psychological distress 
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and the full range of illness perceptions in female cancer patients is consistent with research 
which has found moderate to strong relationships between illness perceptions and 
psychological well-being in a number of illnesses and across male and female populations 
(Hagger & Orbell, 2003; Kaptein et al., 2003). 
In the present review the ‘consequences’ illness perception was the illness perception most 
commonly associated with psychosocial outcomes (including quality of life, changes in health 
practices, psychological distress, posttraumatic growth, fear of recurrence and social and 
emotional support). Perceptions of less severe consequences of the illness were associated 
with better quality of life (Jorgensen et al., 2009) and better psychological well-being 
(Rozema et al., 2009; Silva et al., 2012; Gould et al., 2010; Corter et al., 2013; Mc Corry, 
2013). More severe perceived consequences were associated with changes in health practices 
(i.e. completing more advanced illness behaviours) (Croom et al., 2013). This association 
highlights the important relationship between the way in which a woman perceives the 
consequences of her illness and her psychological well-being. 
In line with research carried out in other physical health populations (Hagger & Orbell, 2003; 
Foxwell et al., 2013; Parfeni et al., 2013), the present review found that, in female cancer 
patients, perceiving greater negative consequences appeared to have the strongest relationship 
with poorer quality of life and elevated psychological distress. These results fit with 
psychological theories, which describe how people’s perceptions of, or thoughts about, 
situations influence their emotional, behavioural (and often physiological) reactions (e.g. 
Beck et al., 1979; Beck, 1995). So it is not surprising that women’s negative beliefs about the 
consequences of their cancer negatively affect their psychological well-being and their quality 
of life.  
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The control and timeline illness perceptions were under-explored in relation to QoL in female 
cancer patients in the present review, with only one study reporting higher quality of life 
associated with higher treatment control beliefs (Jorgensen et al., 2009). Research in other 
physical health populations suggests that a lesser belief in a chronic timeline is associated 
with greater QoL (Scharloo et al., 2007; Alsén, Brink, Persson, Brändström & Karlson, 2010). 
From the analytic approach taken and from the data extracted from the papers it appears that 
the associations between identity, cause, emotional representations and coherence perceptions 
and psychosocial outcomes were the least frequently explored illness perception domains in 
female cancer patients.  
In summary, this review illustrates a complex picture of a multitude of factors related to 
psychosocial well-being and the domains of the self-regulatory model and the possible inter-
relationships between these factors. Overall, the 16 studies reviewed have presented mixed 
results; the analytic approach taken and the data extracted from the papers shows that certain 
dimensions of illness perceptions appear to have been studied more in relation to psychosocial 
outcomes than others (e.g. perceived consequences and control). The reason for which 
dimensions of illness perceptions may have been studied more than others may depend partly 
on the use of different questionnaires across the studies; studies in which the IPQ was used 
may have included only the four scales ‘identity’, ‘control’, timeline’ and ‘consequences’ and 
not the ‘cause’ dimension. Additionally, some studies may have chosen to focus specifically 
on one illness perception dimension (e.g. Henselmans et al., 2009; Rabin et al. 2004; Silva et 
al; 2012). Further studies looking at psychosocial outcomes across all dimensions of the IPQ-
R (in particular emotional representation and coherence) are warranted.  
Additionally, the perceived consequences and control dimensions of the illness perception 
questionnaire are more consistently and strongly associated with some of the psychosocial 
ILLNESS PERCEPTIONS IN CANCER SURVIVORS 
45 
 
outcomes than others (e.g. psychological distress). Further studies investigating the 
relationship between illness perceptions and psychosocial outcomes such as ‘social and 
emotional support’, ‘changes in health practices’, ‘post-traumatic growth’ and ‘coping’ are 
warranted. From the analytic approach taken and from the summary of findings illustrated in 
Table 4 one can conclude that there was a consistent finding across the female cancer groups 
of worsening illness perceptions, poorer quality of life and elevated psychological distress 
(Jorgensen et al. 2009; Millar et al., 2005; Cameron et al., 2005; Silva et al., 2012; 
Henselmans et al., 2009; Gould et al., 2010; Rozema et al., 2009; Rabin et al., 2004; Mc 
Corry et al., 2013; Croom et al., 2013).  
Overall the evidence from the current review suggests that women who experience cognitions 
of a more chronic and cyclical nature, more severe consequences, more symptoms and have 
lower personal and treatment control and a less coherent understanding of the illness tend to 
experience poorer psychosocial outcomes. Negative thoughts can lead women to experience a 
variety of feelings including sadness, anger or anxiety; these in turn can have an impact on a 
women’s bodily sensations (e.g. feeling tense, tired or lethargic) and can influence her 
behaviours (e.g. becoming isolated). These in turn can lead to more negative thoughts, which 
in turn lead to feelings of low mood. This is a vicious cycle in which thoughts, feelings, 
physical sensations and behaviours influence one another and maintain the problem over time. 
Limitations 
There are a number of limitations to the current review. Firstly, the diversity of the 
participants taking part in the studies; these included females with different cancer diagnoses 
(breast, cervix, gynaecological and lung) and at different stages of their cancer journey (some 
with non-metastatic cancer and receiving curative treatment and some at the palliative stage 
ILLNESS PERCEPTIONS IN CANCER SURVIVORS 
46 
 
of care). This variability makes it difficult to generalise the findings as illness perceptions are 
likely to change in relation to type of illness and stage of illness. Additionally, significant 
cultural diversity was apparent across the studies. The studies in the present review originated 
from the UK, USA, Denmark, Portugal, Australia, the Netherlands, New Zealand, Indonesia 
and India. Illness perceptions in some of these cultures may be different to others worldwide. 
For example, Awasthi et al. (2006) found that rural and uneducated women in India held 
strong beliefs in the supernatural causes of illness. These findings reflect the Hindu world-
view and religious philosophy of women, and illustrate a fundamental difference between 
western and Indian belief systems (Awasthi et al., 2006).  
A number of different measures were used to assess illness perceptions and psychosocial 
outcomes across the different studies. Two studies used self-generated questionnaires to 
measure illness perceptions (Awasthi et al., 2006; Awasthi et al., 2010), which may have been 
measuring slightly different concepts to those defined by the self-regulatory model. Drawing 
conclusions may be difficult if the concepts differ between studies, however the authors did 
not explain the reason for which the measure was developed (for example in order to be 
culturally appropriate).  
Another limitation of the studies is that of self-selecting sample bias in many of the studies 
(Jorgensen et al., 2009; Cameron et al., 2005; Henselmans et al., 2009; Gould et al., 2010; 
Rozema et al., 2009; McCorry et al., 2013) i.e. the reasons for which some patients chose not 
to participate may have been due to distress or physical health problems. Furthermore, small 
sample sizes and low power were limitations in some of the studies (Costanzo et al, 2011; 
Henselmans et al., 2009; Duric et al., 2007; Iskandarsyah et al., 2013; Awasthi et al., 2006; 
Awasthi et al., 2010; Jorgensen et al., 2009; Henselmans et al., 2009). In addition, the cross-
sectional design of many of the studies limits the understanding of dynamic processes and 
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possible causal relationships (Silva et al., 2012; Gould et al., 2010; Corter et al., 2013; 
Iskandarsyah et al., 2013).  
The quality checklist of 11 items (Kmet, Lee & Cook, 2004) used to assess the quality of the 
studies included in the review presented a number of issues, which add to the limitations of 
the review. The checklist has a low threshold for quality; for example the quality of two 
studies (Awasthi et al., 2006; Awasthi et al., 2010) seemed lower than the rest even though 
they received a ‘moderate’ quality rating. The method and participant recruitment did not 
appear to be described in sufficient detail. The outcome measures were not sufficiently well 
defined, the sample sizes were quite small and neither of these studies reported any 
limitations. This may highlight a weakness in the quality rating measure in assessing poorer 
quality studies (Kmet et al., 2004). In addition to this, the quality criteria are quite vague (e.g. 
‘Sample size appropriate?’ or ‘Controlled for confounding?’), which reduces the reliability of 
the measure. Another limitation linked to the use of this framework is that several of the 
criteria in the checklist were not applicable to the studies (e.g. ‘If an intervention or random 
allocation was possible, was it described?’; ‘If interventional and blinding of subjects was 
possible, was it reported?’; ‘Outcome and (if applicable) exposure measure(s) well defined 
and robust to measurement/misclassification bias? Means of assessment reported?’). 
Clinical implications  
A number of studies included in this review highlight the importance of developing 
interventions designed to change inaccurate and negative illness perceptions in order to 
improve psychosocial outcomes (Rozema et al., 2009; Iskandarsyah et al., 2013; Costanzo et 
al., 2011). Assessment of illness perceptions can be carried out quickly and easily and can be 
helpful in providing guidance to health care planning (for example by assessing whether a 
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patient’s belief about the ability of their treatment to control their illness or by assessing what 
they believe the consequences of their illness to be) and can potentially support the 
identification of patients at greater risk of negative psychosocial outcomes and mental health 
problems. 
Previously tested psychological hospital-based interventions designed to change negative 
illness perceptions have been found to mediate treatment related improvements and improve 
psychological well-being (Chilcot & Moss-Morris, 2013; Traeger et al., 2013; Petrie et al., 
2002). For example positive change in illness perceptions following intervention was found to 
mediate the treatment effect on improved irritable bowel syndrome symptom severity and 
social adjustment six months later (Chilcot & Moss-Morris, 2013). Intervention programmes 
using the illness perception model have been run with participants experiencing different 
physical illnesses (Hale et al., 2007). Interventions using cognitive-behavioural techniques 
have been found to lead to improvements in participants’ illness perceptions of treatment 
control, reductions in perceptions of the negative emotional impact of the condition and 
reductions in stress levels in Systemic Lupus Erythematosus (Goodman et al., 2005). 
Additionally, interventions have been shown to change/improve illness perceptions related to 
timeline chronicity, severity of consequences and poor perceived control as well as improve 
physical symptomatology in patients who have experienced a myocardial infarct (Petrie et al., 
2002). 
Adequate and sufficient information about which symptoms are related to the illness and 
which consequences to expect in social, financial and emotional functioning is also important 
(Rozema et al., 2009) since satisfaction with information provided has been associated with 
better outcomes, including more positive illness perceptions (Iskandarsyah et al., 2013).  
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Recommendations for future research  
The present review highlights a complex picture of inter-relationships between domains of the 
self-regulatory model and a number of psychosocial outcomes. These are all important factors 
that need to be investigated further within this population. Future research is required, 
including larger samples since some studies with small sample sizes were identified in the 
quality review.  Furthermore, further research using prospective and longitudinal designs 
measuring the dimensions of the self-regulatory model across two or more points in time 
would be helpful as these would give some insight into whether and how illness perceptions 
change over time. Additionally, further studies investigating the relationship between illness 
perceptions and psychosocial outcomes such as ‘social and emotional support’, ‘changes in 
health practices’, ‘post-traumatic growth’ and ‘coping’ are warranted as this review 
highlighted the scarcity of studies investigating these psychosocial outcomes. 
The present review also highlighted a discrepancy between domains of the self-regulatory 
model that have received more attention (identity, cause, consequences, timeline and control) 
and those that appear to attract less interest (emotional representations and coherence). It is 
worth acknowledging however that the emotional representations and coherence subscales are 
newer inclusions in the IPQ-R. However, they might be worth further investigation. 
Conclusion 
Significant associations exist between illness perceptions and psychosocial outcomes in 
female cancer patients. A pattern of relationships between more negative illness perceptions 
and poorer psychosocial outcomes is evident across studies. A pattern of relationships 
between negative illness perceptions and poor psychosocial outcomes was evident across 
studies (Millar et al. 2005; Jorgensen et al., 2009; Cameron et al., 2005; Silva et al. 2012; 
ILLNESS PERCEPTIONS IN CANCER SURVIVORS 
50 
 
Henselmans et al. 2009; Gould et al. 2010; Rozema et al., 2009; Rabin et al. 2004; Corter et 
al., 2013; Mc Corry et al., 2013; Croom et al., 2013). Psychological distress was the construct 
most often measured in the studies and it was also the construct most frequently significantly 
associated with illness perceptions (Cameron et al., 2005; Gould et al. 2010;  Henselmans et 
al. 2009; Jorgensen et al., 2009; Mc Corry et al., 2013; Millar et al. 2005; Rozema et al., 
2009; Silva et al. 2012). The literature in this field however does not currently allow for a 
clear and in-depth understanding of the specific psychosocial factors associated with each 
individual domain of the self-regulatory model in female cancer patients. 
Further research is necessary in order to gain a full and in-depth understanding of the 
psychosocial factors related to each domain of the self-regulatory model in female cancer 
patients. This will be helpful in the identification process of ‘at-risk groups’ and in the further 
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ILLNESS PERCEPTIONS, RESILIENCE AND PSYCHOLOGICAL WELL-
BEING IN CANCER SURVIVORS 
                 




Objective: This study explored the relationship between illness perceptions, resilience and 
psychological well-being in cancer survivors. It was hypothesised that those with lower 
resilience and more negative illness perceptions would experience a poorer quality of life 
(QoL) and poorer psychological well-being.  
Method: A total of 251 cancer survivors (139 male, 112 female) took part in the study. 
Outcome measures completed by participants included measures of illness perceptions, 
resilience, QoL and psychological well-being. 
Results: Age, treatment type, components of the self-regulation model and resilience, 
explained 16.2% of the variability in QoL. The strongest predictors of QoL were resilience 
and perceived consequences, followed by perceived treatment control. Also, age, treatment 
type, components of the self-regulation model and resilience, explained 24.3% of the 
variability in psychosymptomatology. The strongest predictors of psychological distress were 
resilience, then age and perceived consequences, followed by emotional representations and 
treatment control. 
Conclusions: Results are in line with previous studies, showing that there are significant 
relationships between resilience, illness perceptions and psychological well-being in cancer 
survivors. Patients may benefit from psychological interventions to address negative illness 
perceptions and increase resilience. Further research is needed to confirm and expand on these 
findings. 




Over 331,000 people were diagnosed with cancer in 2011 in the UK (Cancer Research UK, 
2014). Improvements in early detection and treatment of different types of cancer have 
substantially improved over the past two decades leading to cancer survival rates in the UK 
doubling in the last 40 years (Cancer Research UK, 2014). Early detection and an ageing 
population have however led to incidence rates rising (DeSantis, Ma, Bryan & Jemal, 2014) 
with the number of cancer survivors increasing by ~3% each year (Maddams, Brewster, 
Gavin, Steward, Elliott, Utley & Møller, 2009). In 2008 there were estimated to be two 
million cancer survivors in the UK (Maddams et al., 2009) and this number is estimated to 
increase to four million by 2030 (Maddams et al., 2009). 
A cancer survivor is someone who has had a diagnosis of cancer in the past, and may or may 
not have an active disease, or is living with progressive disease but is not terminally ill 
(Macmillan Cancer Support, 2011). The NHS Cancer Reform Strategy (Department of 
Health, 2007) states the importance of provision of social and psychological assistance to 
cancer survivors in order to resume ‘as normal a life as they can’. Cancer survivors often find 
it difficult to manage the symptoms of cancer and the side effects of treatment, which have an 
impact on their quality of life (QoL) (DeSantis et al., 2014) including poorer social and 
psychological functioning (Badr & Taylor, 2008; Costanzo, Lutgendorf, Mattes, Trehan, 
Robinson, Tewfik & Roman, 2007; Montazeri, 2008). 
Receiving a diagnosis of a serious illness does not always lead to adverse mental health 
outcomes in all individuals. There is a great variability in response to the diagnosis, with 
some individuals experiencing higher levels of distress, whilst others respond in a more 
resilient way, with less psychological distress (Moskowitz, 2010). Studies have found that up 
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to 58% of cancer patients experience depressive symptoms and up to 38% have major 
depression (Massie, 2004; Williams & Dale, 2006). Resilience is seen as the process of 
effectively negotiating, adapting to, or managing significant sources of stress or trauma 
(Windle, 2011). It is a dynamic process that has been defined as an outcome of successful 
adaptation to adversity (Zautra, Hall & Murray, 2008) and can be seen as a combination of 
abilities that interact to allow an individual to ‘bounce back’, cope and function in spite of 
significant stress or adversity (Tusaie & Dyer, 2004). 
In the past two decades interest in the concept of resilience has increased due to 
dissatisfaction with models that focus on patient psychopathology and illness, and there has 
been a move towards models that focus on patient strengths (Windle, 2011). These deficit 
models tend to define patients in negative terms, focusing on classical risk factors e.g. health 
behaviour, lifestyle and low income without acknowledging positive factors (Harrison, Ziglio, 
Levin & Morgan, 2004). This has led to an increased interest in what protects health in the 
face of adversity and promotes coping abilities of individuals and less dependency on 
professional services (Harrison et al. 2004; Morgan & Ziglio, 2007). Resilience has also 
become more central to policy and practice whereby there is an increasing awareness of the 
importance of the concept in policies and programmes to support improved mental health for 
the whole population (Friedli, 2009). For example, in the UK reports have been recently 
published setting out the types of services, resources and infrastructure needed in order to 
support resilient communities and for mental well-being to improve (Mental Health Strategic 
Partnership, 2013). 
A systematic review carried out by Stewart and Yuen (2011) highlighted a number of 
psychological factors associated with resilience in patients with a chronic physical illness 
such as self-efficacy, self-esteem, internal locus of control, optimism, mastery, hardiness, 
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hope, self-empowerment, acceptance of illness and determination. Given the contribution of 
genetic, environmental, coping factors and past experiences to resilience, regardless of the 
type of adversity encountered, these results were unsurprising (Stewart & Yuen, 2011). This 
review also found that resilience was associated with factors directly salient to physical illness 
such as self-care, adherence to treatment and exercise regimes, and perception of pain 
(Stewart & Yuen, 2011).  
Cancer patients with high resilience have been found to be less dependent on psychosocial 
support to manage their stressful conditions relative to those with low resilience (Brix, 
Schleussner, Füller, Roehrig, Wendt & Strauss et al., 2008). Also, resilience has been found 
to predict patients' fatigue at least in the early stages of radiotherapy (Strauss et al., 2007) and 
has been found to be positively related to QoL in cancer patients (Manne et al., 2014; 
Armando, da Motta, Pinto, Matiello, Da Silva & Ferreira Filho, 2010). 
Illness perceptions, also known as illness representations, are believed to have an important 
role in guiding the decisions people make around managing their treatment regimens and to 
influence their coping strategies and, in turn, have an impact on the individual’s illness 
outcomes and emotional well-being (Leventhal, Halm, Horowitz, Leventhal & Ozakinci, 
2005). A number of studies have shown that people’s cognitive representations of illness are 
made up of a cluster of perceptions that influence behavioural and emotional responses to the 
diagnosis and the treatment of the illness (Leventhal, Meyer & Nerenz, 1980; Traeger et al., 
2009). Leventhal’s Self-regulation Model describes how an individual develops an 
understanding that they are unwell (constructing cognitive representations about the illness or 
disease) and what they do to cope and how they respond to their illness. 
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Illness perceptions can be categorised into five main domains: identity (the label given to the 
illness), cause (beliefs around the perceived biological, emotional, psychological and/or 
environmental cause of the illness), timeline (beliefs about the course/duration of the illness), 
consequences (the consequences of the illness physically, socially and psychologically), 
curability/controllability (beliefs about whether the condition can be cured or kept under 
control). More recently, two further dimensions have been added the model (coherence and 
emotional representations) and the cure/control dimension has been separated into two 
dimensions (treatment control and personal control) (Moss-Morris et al., 2002). Emotional 
representation refers to emotional responses generated by the illness and illness coherence 
refers to the extent to which patients feel they have a clear understanding of the illness (Moss-
Morris et al., 2002). 
Research in recent years has shown that there are strong relationships between illness 
perception domains and physical and psychological well-being (Cameron & Moss-Morris, 
2004; Dorrian, Dempster & Adair, 1999). Meta-analyses and reviews including patients with 
different illnesses (e.g. cancer, diabetes, irritable bowel syndrome, chronic fatigue syndrome) 
have found significant relationships between positive and helpful beliefs and an individual’s 
‘identity’ illness perceptions (the label or name given to the condition and the statements 
regarding beliefs about what symptoms arise from the condition), their belief in the 
controllability of their illness (personal control) and their belief in the appropriateness and 
effectiveness of the treatment (treatment control) (Hagger & Orbell, 2003; Hampson, 1997; 
McSharry, Moss-Morris, & Kendrick, 2011). Conversely, more negative illness perceptions 
(such as emotional representations, identity, consequences and timeline) and were related to 
more maladaptive outcomes (e.g. poorer social and role functioning and psychological 
distress) (Hagger & Orbell, 2003; Hampson, 1997; McSharry et al., 2011).  
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Furthermore, according to Hagger and Orbell’s (2003) meta-analytic review of patients across 
a number of physical health populations, lower perceived consequences and a weaker illness 
identity have been associated with adaptive psychological outcomes including social, physical 
and psychological well-being. Furthermore, more negative illness perceptions have been 
found to predict poorer psychological well-being in men receiving treatment for prostate 
cancer, particularly among men experiencing greater life stress (Traeger et al., 2009). Given 
that negative and unhelpful cognitions are known to be associated with the development and 
maintenance of psychological morbidity (e.g. anxiety and depression) (Beck & Alford, 2009), 
it is important to evaluate and investigate further the relationship between illness perceptions 
and psychosocial outcomes in patients with a cancer diagnosis. 
There is a ‘knowledge gap’ in the research around the relationship between resilience and 
illness perceptions in cancer survivors. Several research studies have investigated the impact 
of resilience on the psychological wellbeing and the quality of life of cancer survivors (e.g. 
Armando et al., 2010; Brix et al., 2008; Manne et al., 2014) and many studies have focused on 
the relationship between illness perceptions and psychological wellbeing and quality of life in 
cancer survivors (e.g. Traeger et al., 2009; Hagger & Orbell, 2003; Hampson, 1997; 
McSharry et al., 2011). To our knowledge however, no studies have looked at the relationship 
between resilience and illness perceptions in cancer survivors and how they impact on 
psychological well-being and quality of life. This study therefore aims to investigate the 
relationship between illness perceptions, resilience, QoL and psychological well-being in 
cancer survivors.  
Given that past research shows that negative illness perceptions have been related to 
maladaptive outcomes including poorer social and role functioning and psychological distress 
(Hagger & Orbell, 2003; Hampson, 1997; McSharry et al., 2011), it was hypothesised that 
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more negative illness perceptions would be associated with poorer QoL and poorer 
psychological well-being.  
Secondly, it was hypothesised that resilience would be associated with more positive illness 
perceptions; resilience was hypothesised to be associated with perceptions of greater 
controllability of cancer, a more coherent perception of cancer, perceptions of less negative 
consequences, perceptions of a less chronic/acute timeline and perceptions of cancer being 
less emotionally loaded. This stems from the definition of resilience as the capacity of 
individuals to successfully maintain or regain their mental health in the face of significant 
adversity or risk (Stewart & Yuen, 2011), and it is believed that this would lead to less more 
realistic and less pessimistic perceptions of the illness. On the other hand, illness perceptions 
about ‘identity’ (the label or name given to the condition and the statements regarding beliefs 
about what symptoms arise from the condition) and ‘cause’ (beliefs about the cause of the 
illness) were not believed to be associated with resilience as they could be seen as ‘more 
objective constructs’ and would therefore not vary as much between more resilient and less 
resilient individuals.  
Thirdly, it was hypothesised that people with greater resilience would not respond as 
adversely to negative illness perceptions compared to those with lower resilience. This was 
hypothesised since negative illness perceptions may have less of an impact on quality of life 
and psychological well-being in more resilient people (i.e. in those who have a greater 
capacity to maintain competent functioning in the face of major life stressors, surmount 
adversity and meet challenges). Receiving a diagnosis of cancer and receiving cancer 
treatment could lead men and women to cope with different stressful events, such as the lack 
of personal autonomy, physical illness and disability, and could have a significant impact on 
work and relationships. It could therefore be hypothesised that greater resilience and more 
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positive consequences, control and emotional representations illness perceptions would 
significantly predict better QoL and psychological well-being in cancer survivors. 
This research could have significant clinical implications, not only in terms of identifying 
cancer survivors who may be more vulnerable to psychological distress, but also in terms of 
informing the development of clinical interventions aimed at improving patients’ 
psychological well-being by targeting unrealistic or negative illness perceptions, correcting 
unhelpful beliefs, enhancing perceptions of control and promoting resilience. 




Participants were identified through a clinical database at the Cancer Centre at University 
Hospital Birmingham. Five hundred and fifty-seven individuals were invited to take part in 
the study. Of those, 256 participants chose to take part, resulting in a 45.9% response rate. 
Forty-nine individuals sent the questionnaire back to record their wish not to participate but 
did not record a reason. Five individuals declined participation stating that they felt too 
physically unwell to take part in the study. The remaining 247 individuals did not return the 
questionnaire. Five participants’ data were excluded due to missing data. Four breast cancer 
patients were male. These scores were excluded from the analyses in order to maintain the 
gender specificity across the prostate and breast cancer groups. Two hundred and forty-seven 
participants were included in the final analyses (135 male, 112 female). 
Ethical approval was granted through the Solihull Research Ethics Committee (Reference 
number 13/WM/0079) and the Research and Development Office at University Hospital 
Birmingham (see Appendix B). The West Midlands Cancer Intelligence Unit (WMCIU) 
reviewed lists of potential participants’ information before questionnaires were posted to 
participants. This was to ensure that patient information was correct and that participants had 
not passed away. Patient data was collected and stored in compliance with the Data Protection 
Act (1998) and the Caldicott Principles (Department of Health, 1997). The present study was 
combined with a study conducted by a fellow trainee clinical psychologist, who was 
recruiting from the same participant group but investigating the role of emotional expression. 
 
Inclusion/exclusion criteria 
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The inclusion criteria were: over 18 years of age, a previous diagnosis of cancer, of any type 
and stage, completed cancer treatment in the previous two weeks to eight months, non 
metastatic cancer/curative treatment, able to speak, read and write in English. Given the 
inclusion of participants with varying cancer diagnoses and treatments, a two-weeks to eight 
months post-treatment selection criterion was adopted in order to capture the quality of life 
and psychological well-being outcomes of all patients in the period immediately following 
cancer treatment as well as in the subsequent months. This selection criterion was also chosen 
for practical reasons, as it enabled the researchers to contact a larger number of participants 
within the limited time available for the study. 
Exclusion criteria were medical status precluding participation (including blindness, current 
hospitalisation, unable to write) and those who were currently or had previously been seen by 
the Mental Health services at the Cancer Centre. Medical notes were accessed to establish 
whether potential participants met inclusion criteria.  
Procedure 
A questionnaire pack (including invitation letter, information sheet and questionnaire) was 
sent out to all the patients who met the inclusion criteria. Those who did not wish to complete 
the questionnaires were asked to return the questionnaires uncompleted in the pre-paid 
envelope provided to ensure researchers were aware of their desire not to participate in the 
study. Individuals who did not return the questionnaire within two weeks of receiving them 
were sent a reminder letter.  
 
Measures 
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Demographic questionnaire 
Sociodemographic characteristics were gathered including gender, date of birth, ethnicity, 
religion, marital status, education, occupation, and hours worked before and after cancer 
diagnosis. Type and stage of cancer diagnosis and treatment(s) received were obtained 
through medical notes. 
The Revised Illness Perception Questionnaire (IPQ-R; Moss-Morris et al., 2002) 
The IPQ-R is divided into three sections, with the identity and causal dimensions presented 
separately from the remaining dimensions (consequences, timeline cyclical/acute, treatment 
control, personal control, coherence and emotional dimensions). A total of 68 items are 
included in the questionnaire. These are rated on a scale of 1 (strongly disagree) to 5 (strongly 
agree). In the present study the IPQ-R was adapted to assess participants’ perceptions about 
their cancer and comprised seven subscales (the identity subscale was excluded): cause, 
timeline, consequences, treatment control, personal control, emotional representation and 
coherence. The questionnaire comprised a total of 52 questions of which 17 questions were 
regarding the perceived causes of the cancer  (e.g. my cancer was caused by stress or worry) 
rated on a yes (1)/no (0) scale. Scores relating to causal items were not included in the data 
analysis since they are used as grouping variables but frequencies of responses were reported. 
The identity subscale was chosen not to be included in the questionnaire since the sample of 
participants had differing cancer diagnoses and it was not possible to develop a generic scale 
that was applicable across a mixed sample. The original version of the IPQ-R was shown to 
be reliable and valid (the Cronbach alpha’s for each of the subscales ranged from 0.79 for the 
timeline cyclical dimension to 0.89 for the timeline acute/chronic dimension) when tested on 
a sample of more than 700 patients with eight different groups of illness (Moss-Morris et al., 
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2002).  
The Connor-Davidson Resilience Scale (CD-RISC; Connor & Davidson, 2003) 
The CD-RISC comprises 25 items used to quantify resilience by measuring five factors 
(personal competence, trust/tolerance/strengthening effects of stress, acceptance of change 
and secure relationships, control, spiritual influences). It was created to address aspects of 
resilience and for use in clinical practice and it measures a person’s self-evaluation of prior 
experience in successfully overcoming stressful events and positive changes. This self-
evaluation requires the presence of a stressor or, alternatively, a person’s recollection of their 
response to a previous stressor (Scali et al., 2012). The CD-RISC was designed to be widely 
applicable to different populations and to assess the extent to which resilience scores can 
change in response to treatment (Connor & Davidson, 2003).  
Each item is scored on a five-point Likert scale ranging from zero (not true at all) to five (true 
nearly all of the time) and is answered based on the respondents’ feelings in the past month. 
The CD-RISC gives an overall score between 0 and 100, with higher scores representing 
greater resilience. The CD-RISC has been employed in a number of previous cancer studies 
(Loprizi, Prasad, Schroeder, & Sood, 2011; Sharpley, Wootten, Bitsika & Christie, 2013). A 
study of the questionnaire’s psychometric properties in general population and patient 
samples showed adequate internal consistency, test-retest reliability (Cronbach’s alpha 
coefficients of 0.89 in the non-clinical group and 0.87 in the clinical sample), and convergent 
and divergent validity (Connor & Davidson, 2003). The CD-RISC was chosen as the most 
appropriate measure of resilience to be adopted given its sound psychometric properties and 
the relevance to the research question asked.  
The Symptom Checklist Revised (SCL-90-R; Derogatis, 1994) 
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SCL-90-R was used to assess patients’ psychological well-being over the past seven days; it 
is a self-rated 90-item checklist objectively evaluating a broad range of symptoms of 
psychopathology across nine symptom dimensions (somatization, interpersonal sensitivity, 
obsessive-compulsive symptoms, depression, anxiety, hostility, phobic anxiety, paranoid 
ideation, and psychotism). The global scale (Global Severity Index; GSI) is considered the 
most reliable indicator of overall distress. Answers are rated on a five point Likert scale 
ranging from 1 (not at all) to 5 (extremely) where higher scores indicate greater distress. The 
SCL-90-R has a high reliability and validity (Cronbach’s alpha coefficient of 0.97 for the 
Global Severity Index) (Prinz, Nutzinger, Schulz, Petermann, Braukhaus & Andreas, 2013), 
and has been used with previous cancer studies (Recklitis, O’Leary, & Diller, 2003; Mulder et 
al., 2014). This measure was adopted in the present study since it has sound psychometric 
properties, it has been used in previous cancer studies, it is a good measure of 
psychopathology and psychological distress and is frequently used in psychotherapy research 
and clinical practice. 
The European Organization for Research and Treatment of Cancer Quality of Life (EORTC 
QLQ-C30; Aaronson et al., 1993) 
The EORTC QLQ-C30 was developed by the European Organization for Research and 
Treatment of Cancer (EORTC) Study Group on Quality of Life. The EORTC QLQ-C30 is a 
30-item self-rated questionnaire that comprises distinct scales, each of which represents a 
different aspect of QoL (including physical, role, emotional, cognitive and social function and 
global health status). Additionally, it includes symptom scales measuring fatigue, 
nausea/vomiting, and six single-item scales: diarrhoea, constipation, appetite loss, insomnia, 
dyspnoea, and financial difficulties. Answers are rated on a four point Likert scale ranging 
from 1 to 4. Higher scores define a more positive level of functioning whilst higher scores 
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indicate a worse level of functioning and more symptoms. Item scores are linearly 
transformed to range from 0 to 100. The questionnaire has been widely used and found to be a 
valid and reliable measure of QoL in cancer populations (Cronbach’s alpha coefficient >0.70) 
(Osoba, Zee, Pater, Warr, Kaizer & Latreille, 1994; Jocham, Dassen, Widdershoven & 
Halfens, 2009; Aaronson et al., 1993). This measure of QoL was chosen since it was 
developed specifically as a measure of QoL in cancer patients; additionally it measures 
different aspect of QoL including physical, role, emotional, cognitive and social function and 
global health status and it has sound psychometric properties as shown in previous research. 
Data analysis 
All data analysis was carried out using IBM SPSS version 21.0 (Statistical Package for the 
Social Sciences). First of all, quality control of the data was carried out by looking for data 
entry errors such as out-of-range values; where maximum or minimum values fell outside the 
possible range, the participant’s questionnaire was checked for the correct score. Where 
missing data were identified, these were substituted with the mean score on the subscale 
(where only one score was missing) (Enders, 2010). If two or more scores were missing on a 
subscale, the participant was excluded from the analysis. Normality testing was carried out 
via standard Shapiro-Wilk testing; given that the scores on the IPQ-R and SCL-90 were not 
normally distributed, nonparametric analyses were carried out. All tests were two-tailed. 
Spearman’s rank correlations were used to explore the relationships between IPQ-R, CD-
RISC, SCL-90-R and EORTC QLQ-C30 subscale scores. Additionally, Hierarchical Multiple 
Regression analyses were performed to examine whether illness perceptions and resilience 
predicted QoL and psychosymptomatology over and above age and type of treatment 
received. Following each regression model, the results were tested for the assumptions of 
multiple regression to make sure the data was suitable for this type of analysis. Each model 
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was checked for the existence of outliers, collinearity of the variables within each model, 
assumption of independent errors, random normal distribution of the errors, homoscedasticity 
and linearity of the data, and non-zero variances. To check for outliers, if the standard 
deviation of our residuals was below -3.29 or above 3.29, the data were observed for potential 
outliers and any found were considered for removal. For collinearity, the Tolerance and VIF 
values of the models were observed. If the Tolerance was less than 0.1 or VIF greater than 10 
for any variable in the model, these variables were further explored and we determined what 
variables to keep in the model. For the assumption of independent errors, we looked for a 
Durbin-Watson value of around 2 from the model results. Anything less than 1 or greater than 
3 was considered a violation of this assumption. To assess random normal distribution of the 
errors, and homoscedasticity and linearity of the data, a few points were observed. First, we 
looked at a histogram of the residuals to check for normality. Second, we observed a Q-Q Plot 
of the residuals, and third, we observed a plot of the residuals by the predicted values. Finally, 
we observed the variances of our variables of interest to determine if these values were 0 or 
not.  
 




Two hundred and forty-seven participants were included in the analyses (135 male, 112 
female). Eighty-seven participants had a diagnosis of breast cancer (35.2%), 92 had a 
diagnosis of prostate cancer (37.2%) and 22 of colorectal cancer (8.9%). Forty-six 
participants had other types of cancer diagnoses (18.3%) including head and neck cancer (n = 
15), skin cancer (n = 11), gynaecological cancer (n = 7), blood cancer (n = 4), lung cancer (n 
= 3) and bone cancer (n = 1). Information on sociodemographic factors (ethnicity, religion, 
marital status, academic attainment and work status) are detailed in Table 4 and clinical 
factors (treatment type, time since treatment and comorbidities) are detailed in Table 5.  
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(n = 87) 
Prostate 
(n = 92) 
Colorectal  
(n = 22) 
Total group 











Mean age  60.8 (12.49) 67.3 (7.86) 64.18 (10.33) 64.72 (11.07) 
Ethnicity White 91.9% 91.3% 86.4% 90.3% 
 Black African/Caribbean 2.3% 5.4% 0% 2.8% 
 Asian 2.3% 2.3% 13.6% 5.2% 
Religion Atheist 11.9% 11.9% 13.6% 11.6% 
 Christian 76.1% 76.1% 59.1% 72.9% 
 Sikh 0% 1.1% 0% 2.4% 
 Hindu 0% 1.1% 0% 0.4% 
 Muslim 13.4% 1.1% 13.6% 2.8% 
 Jehovah ‘s Witness 0% 1.1% 0% 0.4% 
 Spiritualist 0% 1.1% 0% 0.4% 
Marital status Married 71.2% 73.9% 72.7% 73.8% 
 Not married/divorced/widowed 28.8% 26.1% 27.3% 26.2% 
Academic 
attainment 
No qualifications 28.5% 40% 57.1% 37.8% 
 GCSE equivalent 34.5% 26.6% 14.3% 26.8% 
 A level equivalent 16.6% 16.6% 0% 13.0% 
 Degree or higher 20.2% 16.6% 28.6% 20.3% 
  Work status Full time 18.3% 19.6% 13.6% 16.3% 
 Part time 33.3% 20.9% 27.3% 24.3% 
 Retired 41.3% 54.9% 50.0% 52.6% 
 Homemaker/sick leave/student 4.6% 4.3% 4.5% 5.2% 
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Table 5. Clinical factors  
Clinical factors 
Treatment type 
Radiotherapy (in isolation or in 
combination with other 
treatments) 
90.8% 52.2% 36.4% 68.4% 
 Chemotherapy (in isolation or 
in combination with other 
treatments)  
32.1% 1.1% 9.1% 21.8% 
 Surgery (in isolation or in 
combination with other 
treatments) 
67.8% 51.1% 90.9% 54.6% 
Treatment 
combinations 
Radiotherapy only 22.9% 46.7% 0% 34.4% 
 Chemotherapy only 3.4% 0% 9.1% 3.2% 
 Surgery only 1.1% 46.7% 54.5% 23.1% 
 One or more comorbidities 47.3% 47.3% 40.9% 43.2% 
 Time since treatment 
(months) 
4.8 (1.5) 4.8 (1.9) 5.5 (1.9) 4.9 (1.7) 
 Time since diagnosis 
(months) 
11.6 (5.4) 17.3 (16.7) 9.1 (5.2) 12.9 (9.8) 
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Power calculations  
Power calculation using G-Power 3.1.9 computer programme (Faul, Erdfelder, Lang & 
Buchner, 2007) (significance set at p<0.05, power 0.80, effect size f2=0.35), indicated a 
sample size of 207 would be needed for the hierarchical multiple regression to achieve 
significance. The sample size in the present study was therefore sufficiently large to find key 
effects. 
Descriptive statistics for measures obtained 
Sample characteristics for the measures obtained are presented according to treatment group 
(combination of treatment type) (Table 6), cancer type (Table 7) and gender (Table 8) (these 
analyses were conducted only on variables that were hypothesized to be related to illness 
perceptions, resilience, quality of life and psychological wellbeing).  
After Shapiro-Wilk tests showed that none of our measures were normally distributed within 
the treatment, cancer, or gender groups, nonparametric Kruskal-Wallis and Wilcoxon Rank-
Sum tests were used to observe each of the measures by treatment, cancer type, and gender 
groups. Results observing outcomes by treatment groups showed that Physical functioning, 
Fatigue, Dyspnoea, Diarrhoea, and Somatization were significantly different between the 
treatment groups (all p < 0.05) (see Table 6). Results observing outcomes by cancer groups 
showed that Physical functioning, Role Functioning, Emotional Functioning, Global Health 
Scale, Fatigue, Pain, Insomnia, Appetite Loss, Diarrhoea, Interpersonal Sensitivity, Anxiety, 
Hostility, Phobic Anxiety, and Global Scale Index were significantly different between the 
treatment groups (all p < 0.05) (see Table 7). Results showed that average “Emotional 
Representations” were significantly higher for females (3.5, SD=0.9) versus males (3.2, 
SD=0.9), p=0.011. Average resilience measures were significantly higher for males (71.3, 
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SD=14.7) versus females (67.3, SD = 14.9), p=0.033). Additionally, average fatigue was 
significantly higher for females (29.4, SD=22.9) versus males (23.0, SD=22.2), p=0.015 (see 
Table 8). 
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Table 6. Descriptive statistics (Mean & SD) for the measures obtained (by treatment type) 
Mean (SD) 
Treatment Groups 
Measure  Surgery  
(n = 57) 
Chemo   
(n = 85) 
Radio 
(n = 8) 
Surgery + Radio 
(n =153) 
Surgery + Radio + 
Chemo  
(n =69) 
Radio + Chemo 
(n = 22) 
p-value 
Illness perceptions        
Consequences 3.9 (0.5) 3.9 (0.6) 4.0 (0.3) 3.7 (0.7) 4.1 (0.7) 4.2 (0.7) 0.18 
Emotion 
representations 
3.3 (0.9) 3.2 (0.9) 3.4 (0.9) 3.3 (0.8) 3.5 (0.9) 3.8 (0.8) 0.32 
Timeline 2.9 (0.4) 2.9 (0.6) 2.9 (0.3) 2.8 (0.5) 2.8 (0.5) 3.0 (0.6) 0.87 
Treatment control 3.9 (0.4) 4.0 (0.5) 3.8 (0.3) 3.9 (0.4) 3.8 (0.6) 4.0 (0.5) 0.61 
Coherence 3.0 (0.6) 2.8 (0.6) 2.9 (0.6) 3.0 (0.6) 2.9 (0.6) 3.1 (0.7) 0.59 
Personal control 3.4 (0.7) 3.5 (0.5) 3.5 (0.5) 3.4 (0.5) 3.5 (0.5) 3.4 (0.8) 0.94 
Resilience 69.1 (15.1) 71.2 (14.8) 66.4 (8.3) 68.5 (13.8) 68.6 (15.8) 69.3 (18.1) 0.85 
Quality of life        
Physical functioning 87.6 (15.1) 77.7 (22.7) 92.5 (7.5) 86.1 (15.8) 82.2 (15.0) 76.1 (21.9) 0.02 
Role functioning 74.9 (23.6) 76.5 (26.3) 83.3 (17.8) 85.1 (20.7) 82.5 (22.0) 68.1 (32.1) 0.17 
Cognitive 
functioning 
84.8 (17.3) 76.1 (22.9) 81.3 (18.8) 81.3 (19.3) 79.4 (21.7) 69.4 (32.4) 0.28 
Emotional 
functioning 
77.0 (4.5) 75.7 (25.2) 76.0 (26.4) 82.3 (19.3) 76.2 (24.2) 70.8 (26.7) 0.72 
Social functioning 75.7 (25.0) 75.9 (26.3) 70.8 (26.4) 81.9 (22.0) 76.2 (27.2) 63.9 (35.4) 0.56 
Global Health Scale 70.6 (21.9) 65.1 (24.0) 74.0 (12.1) 69.3 (21.3) 63.9 (17.1) 62.5 (17.6) 0.41 
Fatigue 18.1 (19.0) 27.8 (24.2) 23.6 (17.3) 23.4 (23.3) 31.2 (17.1) 39.8(31.2) 0.01 
Nausea 8.2 (13.4) 13.7 (18.9) 12.5 (17.3) 10.8 (14.0) 19.0 (24.3) 12.5 (17.6) 0.42 
Pain 15.5 (26.1) 24.3 (30.4) 12.5 (14.8) 19.4 (23.1) 21.4 (22.4) 25.0 (31.4) 0.42 
Dyspnoea 9.4 (22.5) 22.0 (29.3) 8.3 (15.4) 15.3 (21.7) 12.7 (19.7) 25.0 (32.2) 0.04 
Insomnia 6.4 (19.4) 12.5 (24.1) 12.5 (24.8) 11.8 (26.2) 7.9 (18.0) 30.6 (36.1) 0.07 
Appetite loss 0.6 (4.4) 4.3 (15.2) 0.0 (0.0) 4.9 (18.2) 0.0 (0.0) 11.1 (29.6) 0.17 
Constipation 23.4 (26.7) 35.7 (34.0) 45.8 (35.4) 28.5 (30.7) 38.1 (33.8) 38.9 (27.8) 0.13 
Diarrhoea 15.2 (23.6) 30.6 (31.0) 33.3 (35.6) 19.4 (23.7) 39.7 (32.7) 36.1 (38.8) 0.01 
Financial  20.5 (28.7) 21.6 (31.6) 8.3 (23.6) 12.5 (28.0) 27.0 (35.9) 16.7 (26.6) 0.17 
Psycho-symptomatology 
Somatization 0.4 (0.5) 0.9 (0.9) 0.5 (0.7) 0.6 (0.7) 0.7 (0.6) 0.9 (0.9) 0.01 
OCD 0.5 (0.5) 0.8 (0.8) 0.5 (0.6) 0.6 (0.8) 0.8 (0.8) 1.0 (0.9) 0.16 
Interpersonal 
sensitivity 
0.3 (0.6) 0.5 (0.6) 0.5 (0.7) 0.5 (0.8) 0.5 (0.9) 0.7 (0.8) 0.24 
Depression 0.6 (0.6) 0.8 (0.8) 0.4 (0.7) 0.6 (0.7) 0.7 (0.8) 0.9 (0.7) 0.19 
Anxiety 0.3 (0.5) 0.4 (0.6) 0.4 (0.7) 0.5 (0.7) 0.5 (0.7) 0.7 (0.7) 0.42 
Hostility 0.4 (0.6) 0.4 (0.6) 0.1 (0.1) 0.4 (0.7) 0.4 (0.7) 0.4 (0.6) 0.64 
Phobic anxiety 0.2 (0.4) 0.3 (0.5) 0.1 (0.2) 0.3 (0.6) 0.3 (0.8) 0.5 (0.9) 0.85 
Paranoia 0.2 (0.5) 0.4 (0.6) 0.3 (0.6) 0.2 (0.5) 0.3 (0.7) 0.4 (0.6) 0.12 
Psychoticism 0.3 (0.5) 0.4 (0.5) 0.2 (0.3) 0.3 (0.5) 0.3 (0.4) 0.3 (0.2) 0.91 
Cognitive deficit 0.5 (0.6) 0.9 (0.8) 0.5 (0.7) 0.7 (0.8) 0.9 (0.9) 1.0 (1.0) 0.18 
Global Scale Index 0.4 (0.5) 0.6 (0.6) 0.4 (0.5) 0.5 (0.6) 0.6 (0.7) 0.7 (0.6) 0.18 
ILLNESS PERCEPTIONS IN CANCER SURVIVORS 
 84 
Table 7. Descriptive statistics for the questionnaire responses (by cancer type) 
Mean (SD) 
Measure Prostate 
(n  = 92) 
Breast 
(n = 87) 
Colorectal  





Illness Perceptions      
Consequences 3.9 (0.5) 3.9 (0.7) 4.0 (0.5) 4.1 (0.5) 0.12 
Emotional representations 3.2 (0.9) 3.4 (0.9) 3.3 (0.9) 3.5 (0.8) 0.13 
Timeline 2.9 (0.5) 2.8 (0.5) 2.8 (0.4) 2.9 (0.5) 0.43 
Treatment control 4.0 (0.5) 3.9 (0.5) 3.8 (0.4) 3.9 (0.5) 0.35 
Coherence 2.9 (0.6) 3.0 (0.6) 3.0 (0.7) 2.9 (0.6) 0.83 
Personal control 3.4 (0.6) 3.4 (0.5) 3.5 (0.5) 3.4 (0.5) 0.79 
Resilience 71.7 (15.6) 69.5 (13.9) 66.8 (12.7) 66.4 (15.8) 0.21 
Quality of life      
Physical functioning 86.0 (182) 86.0 (18.2) 79.1 (16.8) 73.2 (24.5) 0.01 
Role functioning 77.4 (22.9) 77.4 (22.9) 81.1 (22.6) 67.4 (31.6)  0.03 
Cognitive functioning 83.5 (17.7) 83.5 (17.7) 78.0 (23.2) 72.5 (25.9) 0.13 
Emotional functioning 81.8(19.5) 81.8 (19.5) 66.3 (28.6) 69.4 (29.5) 0.03 
Social functioning 76.5 (22.4) 75.4 (24.8) 73.5 (26.6) 68.8 (30.3)  0.09 
Global Health Scale 66.8 (20.7) 70.9 (23.5) 64.0 (19.0) 61.4 (19.5) 0.02 
Fatigue 25.9 (22.6) 19.1 (19.1) 31.3 (22.4) 35.7 (29.2) 0.01 
Nausea 12.1 (17.1) 9.2 (16.3) 15.2 (17.7) 15.6 (18.4) 0.09 
Pain 20.6 (26.7) 14.3 (24.4) 30.3 (31.1) 27.2 (30.9) 0.01 
Dyspnoea 16.6 (25.8) 12.7 (22.6) 19.7 (32.0) 23.9 (30.4) 0.14 
Insomnia 11.5 (24.3) 4.7 (13.6) 7.6 (20.4) 30.4 (35.7) < 0.0001 
Appetite loss 3.1 (13.9) 1.1 (6.0) 3.0 (9.8) 10.9 (28.2) 0.02 
Constipation 32.5 (32.1) 29.3 (30.8) 30.3 (28.9) 34.1 (32.6) 0.65 
Diarrhoea 26.4 (29.7) 19.2 (25.8) 31.8 (33.3) 37.0 (30.8) 0.01 
Financial difficulties 20.1 (30.2) 18.5 (29.0) 33.3 (30.9) 23.2 (35.0) 0.06 
Psychosymptomatology      
Somatization 0.6 (0.7) 0.6 (0.7) 0.7 (0.7) 0.9 (1.0) 0.07 
Obsessive compulsive 0.6 (0.7) 0.6 (0.6) 0.5 (0.7) 1.0 (1.0) 0.07 
Interpersonal sensitivity 0.4 (0.6) 0.4 (0.6) 0.5 (0.7) 0.8 (0.9) 0.01 
Depression 0.6 (0.6) 0.6 (0.7) 0.6 (0.7) 1.0 (0.9) 0.05 
Anxiety 0.3 (0.5) 0.4 (0.5) 0.4 (0.5) 0.7 (0.9) 0.03 
Hostility 0.4 (0.6) 0.3 (0.4) 0.4 (0.6) 0.6 (0.8) 0.03 
Phobic anxiety 0.2 (0.4) 0.2 (0.5) 0.1 (0.2) 0.6 (0.9) 0.01 
Paranoia 0.3 (0.5) 0.2 (0.4) 0.2 (0.5) 0.6 (0.9) 0.05 
Psychoticism 0.4 (0.5) 0.2 (0.3) 0.2 (0.4) 0.5 (0.6) 0.07 
Cognitive deficit 0.7 (0.7) 0.7 (0.7) 0.6 (0.6) 1.0 (1.0) 0.23 
Global Scale Index 0.4 (0.5) 0.5 (0.5) 0.5 (0.5) 0.8 (0.8) 0.03 
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Table 8. Descriptive Statistics and Wilcoxon Rank-Sum Results for the Measures (by gender) 
Mean (SD)  
Measure Male (n = 135) Female (n = 112) p-value 
IPQ-R    
Consequences 3.9 (0.5) 3.9 (0.6) 0.91 
Emotional representations 3.2 (0.9) 3.5 (0.9) 0.01 
Timeline 2.9 (0.5) 2.8 (0.5) 0.53 
Treatment control 3.9 (0.5) 3.8 (0.5) 0.05 
Coherence 2.9 (0.6) 2.9 (0.6) 0.95 
Personal control 3.5 (0.6) 3.4 (0.5) 0.18 
Resilience 71.3 (14.7) 67.3 (14.9) 0.03 
Quality of life    
Physical functioning 82.3 (21.2) 82.1 (16.1) 0.17 
Role functioning 75.9 (25.7) 80.5 (22.8) 0.21 
Cognitive functioning 81.5 (20.6) 76.9 (22.8) 0.12 
Emotional functioning 78.1 (23.2) 75.9 (24.9) 0.47 
Social functioning 73.6 (26.7) 79.3 (23.7) 0.09 
Global health status 68.5 (23.0) 65.6 (19.8) 0.11 
Fatigue 23.0 (22.2) 29.4 (22.9) 0.01 
Nausea 11.7 (17.4) 12.4 (17.0) 0.64 
Pain 19.3 (28.0) 22.2 (25.2) 0.10 
Dyspnoea 16.5 (27.0) 16.7 (24.5) 0.70 
Insomnia 9.9 (22.7) 13.4 (26.3) 0.26 
Appetite loss 2.5 (10.5) 3.9 (26.3) 0.89 
Constipation 29.4 (29.9) 36.3 (34.2) 0.14 
Diarrhoea 24.4 (29.1) 28.3 (30.4) 0.29 
Financial difficulties 19.8 (30.3) 20.5 (30.4) 0.74 
Psychosymptomatology    
Somatization 0.6 (0.8) 0.7 (0.7) 0.21 
Obsessive compulsive 0.7 (0.7) 0.7 (0.7) 0.55 
Interpersonal sensitivity 0.4 (0.6) 0.5 (0.8) 0.33 
Depression 0.7 (0.7) 0.8 (0.8) 0.72 
Anxiety 0.4 (0.6) 0.5 (0.7) 0.075 
Hostility 0.4 (0.6) 0.3 (0.6) 0.18 
Phobic anxiety 0.2 (0.5) 0.3 (0.7) 0.22 
Paranoia 0.3 (0.6) 0.3 (0.6) 0.23 
Psychoticism 0.3 (0.5) 0.3 (0.5) 0.99 
Cognitive deficit 0.7 (0.8) 0.8 (0.8) 0.75 
Global Scale Index 0.5 (0.6) 0.6 (0.6) 0.28 
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IPQ-R Cause subscale  
The mean scores for each of the cause items are shown in Table 9. ‘Chance or bad luck’ was 
the most strongly endorsed cause for cancer, followed by ageing and stress and worry. The 
least favoured attributions were mental attitude e.g. thinking about life negatively and 
personality.  
 








 Hereditary/runs in the family 45 (19.4%) 
 Germ or virus 16 (6.8%) 
 Eating habits 31 (12.9%) 
 Chance or bad luck 154 (65%) 
 Poor medical care in the past 15 (6.4%) 
 Pollution in the environment 29 (12.3%) 
 Mental attitude e.g. thinking about life negatively 7 (2.9%) 
 Family problems or worries 27 (11.3%) 
 Overworking 17 (7.2%) 
 Emotional state e.g. feeling down, lonely, anxious, empty 18 (7.5%) 
 Ageing 99 (41.4%) 
 Alcohol 16 (6.6%) 
 Smoking 16 (6.6%) 
 Personality 6 (2.5%) 
 Altered immunity 31 (13.1%) 
 Pressure at work 18 (7.5%) 
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Correlation analysis  
Correlations between the IPQ-R subscales, the total resilience score (CD-RISC), the quality of 
life score (EORTC QLQ-C30 Global Health Status) and the SCL-90 depression, anxiety and 
global symptom index scores are presented in Table 10. Significant relationships (weak to 
moderate) between the scales were apparent. Greater scores on the IPQ-R consequences 
subscale were significantly associated with poorer physical functioning, role functioning, 
cognitive functioning, emotional functioning, social functioning, and the global health scale 
on the EORTC QLQ-C30. IPQ-R consequences were positively associated with fatigue, 
nausea, pain, dyspnoea, insomnia, constipation, diarrhoea, and financial difficulties on the 
EORTC QLQ-C30. The IPQ-R consequences subscale was positively associated with 
somatisization, obsessive compulsive, interpersonal sensitivity, depression, anxiety, hostility, 
phobic anxiety, paranoia, psychoticism, cognitive deficit and global scale index on the SCL-
90.  
Greater scores on the emotional representations subscale of the IPQ-R were significantly 
associated with poorer physical functioning, role functioning, cognitive functioning, 
emotional functioning, social functioning, and the lower scores on the global health scale on 
the EORTC QLQ-C30. IPQ-R emotional representations were positively associated with 
fatigue, nausea, pain, appetite loss, insomnia, constipation, diarrhoea, and financial 
difficulties on the EORTC QLQ-C30. The IPQ-R emotional representations subscale was 
positively associated with somatisization, obsessive compulsive, interpersonal sensitivity, 
depression, anxiety, hostility, phobic anxiety, paranoia, psychoticism, cognitive deficit and 
global scale index on the SCL-90.  
Greater scores on the IPQ-R timeline subscale were significantly associated with poorer role 
functioning, cognitive functioning, emotional functioning, social functioning, and lower 
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scores on the global health scale on the EORTC QLQ-C30. IPQ-R timeline subscale was 
positively associated with pain, dyspnoea, financial difficulties on the EORTC QLQ-C30.  
The IPQ-R timeline subscale was positively associated with somatisization, obsessive 
compulsive, depression, hostility, phobic anxiety, psychoticism, cognitive deficit and global 
scale index on the SCL-90.  
There were significant positive associations between the treatment control subscale of the 
IPQ-R and emotional functioning and the global health scale on the EORTC QLQ-C30. 
Greater scores on the IPQ-R treatment control subscale were associated with lower scores on 
the pain, diarrhoea and financial difficulties subscales of the EORTC QLQ-C30.  Greater 
scores on the IPQ-R treatment control subscale were significantly associated with lower 
scores on the somatisization, depression, phobic anxiety, psychoticism subscales of the SCL-
90.  
There were significant associations between greater perceived coherence on the IPQ-R and 
higher social functioning, nausea and diarrhoea on the EORTC QLQ-C30. Greater perceived 
coherence was also associated with lower scores on the depression and paranoia scales of the 
SCL-90. 
There were significant positive associations between IPQ-R personal control and the global 
health scale on the EORTC QLQ-C30. Poorer scores on the personal control subscale of the 
IPQ-R were associated greater scores on the ‘appetite loss’ subscale of the EORTC QLQ-C30 
and with greater scores on the phobic anxiety subscale of the SCL-90. 
Greater resilience scores were significantly correlated with lower scores on the emotional 
representations subscale of the IPQ-R. Resilience was also significantly positively correlated 
with IPQ-R treatment control.  Additionally, resilience was significantly positively associated 
with the Global Health Status score on the EORTC QLQ-C30 and was significantly 
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associated with lower scores on the anxiety, depression and Global Scale Index of the SCL-
90.
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*p < 0.05 ; **p < 0.01.
































           
SCL90 -
Depression 
-.57** -           
SCL90  Anxiety -.53** .80** -          
SCL90  GSI -.58** .94** .86** -         
Resilience .33** -.37** -.41** -.35** -        
IPQ-R 
Consequences 




-.26** .36** .39** .36** -.41** .53** -      
IPQ-R Timeline -.16** .17** .08 .13* -.10 .25** .29** -     
IPQ-R Treatment 
control 
.23** -13** -.08 -.10 .17** -.05 -14* -.28** -    
IPQ-R Coherence .10 -.14* -.11 -.11 .07 -.03 -.17** -.12 -.01 -   
IPQ-R Personal 
control 
.12 -.05 -.06 -.01 .12 .14* -.04 -.10 .28** .02 -  
Age  .07 -.16** -.20** -.16** 0.6 -.31** -.25** -.06 .20 -.13* -.12* - 
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T-Tests and Shapiro-Wilk tests 
We thought it would be interesting to investigate differences between the two main cancer 
groups (breast and prostate) to see whether these differed significantly on measures of quality 
of life, psychosymptomatology and resilience. We thought that this would also be helpful in 
interpreting the results of the hierarchical multiple regression analysis carried out in the breast 
and prostate groups separately (Appendices C, D, E & F). Table 11 displays the results of 
tests carried out between the prostate and breast cancer subgroups and illustrates the means 
and standard deviations for each group and significant differences on the measures of quality 
of life, psychosymptomatology and resilience. Shapiro-Wilk tests were used to observe 
normality of each measure between the prostate/breast cancer groups. Age and CD-RISC 
were normally distributed between the groups, therefore a Two-Sample t-test was used. All of 
the other measures were not normally distributed, therefore a Wilcoxon-Rank Sum test was 
used. Significant differences were found between the two groups in age (t = 4.2, p <0.0001). 
Significant differences were also found in Fatigue (Z = 2.6, p = 0.009), and Pain (Z = 2.7, p = 
0.008). For both Fatigue and Pain, Breast Cancer measures were significantly higher than 
Prostate.  
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Table 11. Resilience, quality of life and psychological symptoms split according to breast 





N = 92 
Breast cancer 
group 
N = 87 
  
  Mean (SD) Mean (SD) Test 
Statistic 
(t or Z) 
p 
AGE  67.3 (7.9) 60.8 (12.5) 4.2 <0.0001* 
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Regression analyses 
Univariate regression analyses were run separately observing age, gender, marital status, time 
since treatment, time since diagnosis, and treatment type (surgery yes/no, chemotherapy 
yes/no, and radiotherapy yes/no) received, by the dependent variables (SCL90-R, EORTC 
QLQ-C30, CD-RISC, IPQ-R).  
Age was found to be a significant predictor of the Global Symptom Index on the SCL90-R 
(F(1, 241) = 12.29, p < 0.001) and a significant predictor of the consequences subscale on the 
IPQ-R (F(1, 246) = 31.65, p < 0.001), the emotion representations scale on the IPQ-R (F(1, 
262) = 19.15, p < 0.001) and personal control scale on the IPQ-R (F(1, 246) = 4.59, p < 0.05). 
Age however was not a predictor of EORTC QLQ-C30 scores or CD-RISC scores.  
Time since diagnosis significantly predicted scores on the emotional representations scale of 
the IPQ-R (F(1, 121) = 7.81, p < 0.01), on the timeline scale of the IPQ-R (F(1, 121) = 4.67, p 
< 0.05) and on the coherence scale of the IPQ-R (F(1, 121) = 4.99, p < 0.05). Time since 
diagnosis did not significantly predict any of the other dependant variables.  
Time since treatment significantly predicted coherence scores on the IPQ-R (F(1, 244) = 6.89, 
p<0.05) but did not significantly predict any of the other dependant variables. 
Having received radiotherapy treatment significantly predicted Global Symptom Index on the 
SCL90-R (F(1, 236) = 4.18, p < 0.05) but did not significantly predict any of the other 
dependant variables. 
Having received chemotherapy significantly predicted scores on the consequences subscale of 
the IPQ-R (F(1, 241) = 4.87, p < 0.05) and on the emotional representations subscale of the 
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IPQ-R (F(1, 241) = 4.12, p < 0.05) but did not significantly predict any of the other dependant 
variables. 
Gender was found to be a significant predictor of the emotion representations scale on the 
IPQ-R (F(1, 246) = 5.79, p < 0.05) but did not significantly predict any of the other dependant 
variables.  
Marital status was found to be a significant predictor of the treatment control subscale of the 
IPQ-R (F(1, 246) = 9.28, p < 0.005) and of the personal control subscale of the IPQ-R (F(1, 
246) = 8.06, p < 0.005). Marital status did not significantly predict any of the other dependant 
variables. 
Hierarchical multiple regression 
Hierarchical multiple regression analyses were performed to examine whether illness 
perceptions and resilience predicted QoL and psychosymptomatology over and above age and 
type of treatment received. Age and treatment type received were included in the multiple 
regression because these variables were significant in the univariate regression analyses. 
These analyses were carried out for the cancer group as whole and subsequently the subgroup 
of prostate cancer patients and the subgroup of breast cancer patients. The results of the 
secondary analyses in the prostate and breast cancer subgroups are included in the appendices 
(C, D, E & F) and are not discussed in the current study. 
All final models were checked for assumptions/diagnostics of multiple regression, including 
the existence of outliers, collinearity of the variables, assumption of independent errors, 
random normal distribution of the errors, homoscedasticity and linearity of the data, and non-
zero variances. Results showed all assumptions were met and there were no outliers to assess 
or collinearity. 
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In each analysis, a forward-selection approach was used to create each multivariable model. 
Age and type of treatment received were entered on the first step. The components of the self-
regulation model were entered on the second step and in order to determine whether resilience 
improves the ability to predict quality of life and psychological well-being beyond the 
components of the self regulation model, resilience was entered on the third step.  
As shown in Table 12, age and type of treatment received were not significant predictors of 
QoL. The components of the self regulation model increased the adjusted R-Squared to 9.2%, 
F(10, 230) = 3.43, p<0.01. The adjusted R-Squared in QoL was again increased to 16.2% 
with the addition of resilience, F(11, 229) = 5.21, p<0.001. A test comparing the R-Squared 
values in the nested models showed that none of the increases were statistically significant. 
The strongest predictors of QoL were resilience and perceived consequences, followed by 
perceived treatment control (Table 12).  
As shown in Table 13, our first model explained 6.2% of the variability in 
psychosymptomatology F(4, 231) = 4.85, p < 0.001. The components of the self regulation 
model increased the R-Squared to 16.9%, F(10, 225) = 5.79, p<0.001. The explained 
variability in psychosymptomatology was increased to 24.3% with the addition of resilience, 
F(11, 224) = 7.86, p<0.001. A test comparing the R-Squared values in the nested models 
showed that none of the increases were statistically significant. The strongest predictors of 
psychological distress were resilience, then age and perceived consequences, followed by 
emotional representations. (Table 13). 
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Table 12. Hierarchical multiple regression analysis for the predictors of quality of 
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DISCUSSION 
Summary of findings 
This study aimed to investigate the relationship between illness perceptions, resilience, QoL 
and psychological well-being in cancer survivors. It was hypothesised that more negative 
illness perceptions would be associated with poorer QoL and poorer psychological well-
being. Secondly, it was hypothesised that resilience would be associated with more positive 
illness perceptions (i.e. perceptions of cancer as being more controllable, more coherent, 
perceptions of less negative consequences, a less chronic/acute timeline and being less 
emotionally loaded). Thirdly, it was hypothesised that greater resilience and more positive 
consequences, control and emotional representations illness perceptions would significantly 
predict better QoL and psychological well-being in cancer survivors. 
 
Firstly, negative perceived consequences, emotional representations and timeline were found 
to be associated with greater levels of psychological distress and poorer QoL. Additionally, 
greater treatment control was associated with a greater QoL. These results are consistent with 
previous research that shows that more negative illness perceptions (such as emotional 
representations, identity, consequences and timeline) are related to more maladaptive 
outcomes (e.g. poorer social and role functioning and psychological distress) (Hagger & 
Orbell, 2003; Hampson, 1997; McSharry et al., 2011). Furthermore, previous research shows 
that negative perceived consequences have been associated with poorer psychological well-
being and poorer QoL outcomes in cancer patients as well as in other physical health 
populations (Hagger & Orbell; 2003, Scharloo et al., 2007, Trager et al., 2009) and negative 
beliefs in a chronic timeline have been associated with poorer QoL (Scharloo et al., 2007). 
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The present study’s findings are also in line with previous research reporting associations 
between positive treatment control beliefs and a greater QoL (Jorgensen et al., 2009).  
Secondly, it was hypothesised that resilience would be associated with a more positive profile 
of illness perceptions. Lower resilience scores were significantly associated with negative 
emotional representations whilst higher resilience scores were significantly associated with 
perceptions of greater treatment control and personal control. No previous studies have 
explored the relationship between resilience and illness perceptions in cancer patients. 
Research in other physical health populations is scarce but associations have been found 
between greater resilience and smaller perceived consequences in women experiencing hot 
flushes or night sweats during menopause (Duffy, Iversen, Aucott & Hannaford, 2013). 
Several studies have found significant associations between self-efficacy and resilience 
(Smith & Zautra, 2008; Schiaffino & Revenson, 1992; Yi, Vitaliano, Smith, Yi & Weinger, 
2008) across various physical health populations; one could speculate that greater perceived 
treatment and personal control could be related to self-efficacy. Interest in understanding the 
relationship between resilience and illness perceptions in physical health populations is 
growing (Duffy et al., 2013; Chew, Shariff-Ghazali & Fernandez, 2014). 
Thirdly, it was hypothesised that illness perceptions (consequences, control and emotional 
representations) and resilience would significantly predict QoL and psychological well-being 
in cancer survivors. The results of the hierarchical regression revealed that both resilience and 
some of the individual components of the self-regulation model were able to predict QoL and 
psychosymptomatology in cancer survivors. The strongest predictors of QoL were resilience 
and perceived consequences, followed by perceived treatment control. The strongest 
predictors of psychological distress were resilience and age, followed by perceived 
ILLNESS PERCEPTIONS IN CANCER SURVIVORS 
 99 
consequences and emotional representations.  The results of the regression analyses showed 
that the only illness perception subscales that made significant unique contributions to the 
variance in outcome scores were perceived consequences, emotional representations and 
treatment control.  
These findings fit with psychological theories, which describe how people’s perceptions of, or 
thoughts about, situations influence their emotional, behavioural (and often physiological) 
reactions (e.g. Beck et al., 1979; Beck, 1995). The cognitive behavioural model can be helpful 
in conceptualising the findings of the present study; according to this model negative thoughts 
can lead to experiencing a variety of feelings including sadness, anger or anxiety; these in turn 
can have an impact on bodily sensations (e.g. feeling tense, tired or lethargic) and can 
influence her behaviours (e.g. becoming isolated). These in turn can lead to more negative 
thoughts, which in turn lead to feelings of low mood.  
The results from the present study are consistent with the possibility of models that suggest 
that illness perceptions may have an impact on quality of life and psychological wellbeing 
through the mediation of the emotional and behavioural impact they have. According to such 
models, the experience of negative emotional representations in cancer survivors can affect 
their cognitions and behavioural reactions, in turn leading to poorer quality of life and poorer 
psychological wellbeing. Furthermore, lower beliefs in treatment control in cancer survivors 
could be related to beliefs about a more negative outcome and consequences as well as more 
negative emotional representations, which in turn leads to poorer outcomes (psychological 
wellbeing and quality of life). However, further research is needed in order to establish this 
possibility. 
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In a similar way, Leventhal’s Common Sense model can be a helpful framework in 
conceptualising the findings of the present study. According to this model, illness 
representations guide a person’s evaluation of an illness situation and their behaviours in 
response to this situation. Two processing systems work simultaneously; one system is 
dedicated to the cognitive processing of stimuli (external or internal) and the other system is 
dedicated to the emotional processing of the same stimuli. As a consequence, both cognitive 
and emotional processes can trigger health behaviours (Leventhal, Diefenbach & Leventhal, 
1992). The thought of cancer in itself is often a trigger of cognitions about suffering and 
potentially life-threatening consequences and prolonged treatment with uncertain outcomes. 
These representations triggered by thoughts of cancer can simultaneously trigger an intense 
emotional reaction of anxiety and fear. Therefore, a cancer survivors’ experience of negative 
illness representations about the consequences of cancer and/or treatment control could lead 
to the person’s emotional reactions during these cognitive processes, as conceptualized in the 
parallel processing model, to change, resulting in a poorer quality of life and poorer 
psychological wellbeing.  Likewise, negative emotional representations of cancer are likely to 
lead to a poorer quality of life and poorer psychological wellbeing in cancer survivors.  
 
The findings of the present study also fit with previous research that shows that resilience 
predicts QoL and psychological well-being both in those with cancer (Sharpley, Bitsika, 
Wooten & Christic, 2014; Ryu & Yi, 2013; Min et al., 2013; Strauss et al., 2007) and in other 
clinical and non-clinical populations (Bonanno, 2005; Mautner, 2013; Nygren, Aléx, Jonsén, 
Gustafson, Norberg & Lundman, 2005; Hildon, Montgomery, Blane, Wiggins & Netuveli, 
2009). Previous research shows that several other factors have a role in reducing the risk of 
developing depression in cancer patients. These include factors like hopefulness (Vellone, 
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Rega, Galletti & Cohen 2006), spirituality (Wenzel, Donnelly, Fowler, Habbal, Taylor, Aziz, 
& Cella, 2002) and family/social support (Orbuch, Parry, Chesler, Fritz, & Repetto, 2005, 
Kroenke, Kubzansky, Schernhammer, Holmes & Kawachi 2006). Resilience has also been 
found to be the strongest predictor of fatigue early in radiotherapy treatment, suggesting that 
the psychological ability to manage stress related to threat and illness can also influence levels 
of fatigue (Strauss et al., 2007). Resilience could be seen as a buffer variable between stress 
and depression (Luthar & Cicchetti 2000); the present study supports previous research that 
suggests that resilience may be a protective factor for cancer patients’ mental well-being 
(Luthar & Cicchetti 2000; Min et al., 2013) by independently contributing to low emotional 
distress in cancer patients (Min et al., 2013).  
The present study also highlighted interesting relationships between resilience and IPQ 
variables; resilience was associated with perceptions of cancer as being less emotionally 
loaded and it was also associated with perceptions of cancer treatment being more 
controllable. This may be because people with higher resilience scores have a greater capacity 
to ‘bounce back in the face of adversity’ and have a more positive outlook on negative 
situations (i.e. illness and treatment), leading to more positive cognitions about treatment 
control and to perceptions of cancer as being less emotionally loaded. Greater resilience and 
more positive beliefs regarding treatment control and emotional representations of cancer also 
predicted better quality of life and psychological well-being in cancer survivors. So this study 
has identified a potential explanatory link between illness perceptions and quality of life using 
resilience.  
The results of the present study also replicate previous findings that illustrate significant 
relationships between on the one hand negative illness perceptions and, of the other hand, 
poorer QoL and lower mood in cancer patients (Silva et al., 2012; Gould et al., 2010; Rozema 
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et al., 2009; McCorry et al., 2013; Jorgensen et al.; 2009). Research has shown that illness 
perceptions can explain a significant proportion of variance in levels of distress in cancer 
populations (Llewellyn et al., 2007; Scharloo et al., 2005; Millar et al., 2005) as well as in 
other chronic illnesses (e.g. Cartwright et al., 2009; Dorrian et al., 2009). Studies in cancer 
patients have found that negative illness perceptions predict worse health-related QoL and 
depression after treatment (Chaboyer, Lee, Wallis, Gillespie & Jones, 2010; Traeger, Penedo 
& Gonzalez 2009) and timeline perceptions have been found to predict distress at six and 12 
months following breast surgery (Millar et al., 2005). Additionally, higher levels of anxiety 
and depression have been found in female cancer patients who hold stronger beliefs in chronic 
and cyclical timeline, more severe consequences, more symptoms and lower personal and 
treatment control and a less coherent understanding of the illness (Mc Corry et al., 2013). 
Previous research has identified differences between cancer types and time since treatment, 
with skin cancer survivors reporting less negative consequences and patients who had recently 
received cancer treatment experiencing more negative consequences and greater perceptions 
of timeline chronicity (Hopman & Rijken, 2015). Additionally, characteristics such as illness 
duration and treatment type/stage may have an impact on cancer patients’ experiences and 
influence their illness perceptions (Hopman &  Rijken, 2015). Different levels of perceived 
personal control have in fact been found in short-term and long-term colorectal cancer 
survivors (Mols et al., 2012).  
In the present study treatment type did not predict quality of life or psychological well-being; 
this may be due to the majority of participants having received radiotherapy treatment in 
combination with other treatments. It was therefore not possible to clearly differentiate 
between the chemotherapy, radiotherapy or surgery treatment groups and it is possible that the 
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effects of treatment were hidden due to having a combination of treatments or by the length of 
time since treatment.  
Strengths and limitations 
This study is the first to explore the relationship between resilience and illness perceptions in 
cancer patients. The results show that greater resilience is associated with perceptions of 
greater treatment control and personal control whilst negative emotional representations are 
associated lower resilience. These findings add to the existing literature that explores the 
effects of illness perceptions and resilience on psychological well-being and quality of life in 
cancer patients. The sample size in the present study was sufficiently large to find key effects 
whilst minimising type II errors. 
There are a number of limitations to this study. Firstly there may have been a self-selecting 
sample bias; information was not gathered on why non-responders chose not to take part. The 
reasons for which some patients chose not to participate may have been due to distress or 
physical health problems; this information would have been useful in understanding 
differences between responders and non-responders and understanding whether the 
differences had an impact on the results. 
Secondly, the majority of the participants who took part in the study had received 
radiotherapy treatment alone (34.4%) or in combination with other treatments (34%); this was 
due to the recruitment procedure and the assistance of radiotherapy nurses who helped 
identify eligible participants. The remaining participants (31.6%) received other treatments 
(chemotherapy and/or surgery but not radiotherapy). This may limit the generalisability of the 
findings to patients who have undergone primarily surgery or chemotherapy treatments and it 
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makes it more difficult to identify the differences in illness perceptions and resilience in these 
different treatment groups.  
Thirdly, there was a great variability within the patient group in terms of time since diagnosis, 
number of treatments and treatment combinations received, as it is difficult to control for all 
these variables when working with this kind of population. Since the participants in the 
current study had non-metastatic cancer and took part in the study within eight months 
of completing cancer treatment, caution must be made when generalising these results to other 
cancer populations (e.g. terminally ill patients) as their resilience and illness perceptions may 
well be different (Monroe & Oliviere, 2007; Temel et al., 2011). 
Another limitation is that social support was not assessed in the present study. Social support 
has been related to less severe perceptions of consequences of illness and greater perceptions 
of control in breast cancer patients (Awasthi et al., 2006) whilst a lack of social support has 
been linked to poor psychological outcomes in cancer patients (Kroene et al., 2006; 
Luszczynskaa, Mohamed  & Schwarzer, 2005; Hipkins et al., 2004). 
Clinical implications 
This research could have significant clinical implications; not only in terms of identifying 
cancer survivors who may be more vulnerable to psychological distress but also in terms of 
informing the development of clinical interventions aimed at improving patients’ 
psychological well-being by targeting unrealistic or negative illness perceptions, correcting 
unhelpful beliefs, enhancing perceptions of control and promoting resilience. Assessing for 
levels of resilience soon after diagnosis may help with the identification of vulnerable 
patients. Resilience training has been evaluated in previous research in different clinical and 
ILLNESS PERCEPTIONS IN CANCER SURVIVORS 
 105 
non-clinical populations with meaningful outcomes including greater resilience scores, 
improved coping strategies and improved psychological well-being (Steinhardt & Dolbier, 
2008; Bradshaw et al., 2007; Waite & Richardson, 2004; Loprinzi et al., 2011). The Stress 
Management and Resilience Training (SMART) program has been found to significantly 
improve resilience and reduce stress and anxiety in a group of breast cancer patients (Loprinzi 
et al., 2011). Resilience training is often structured as a psycho-educational programme 
designed to enhance personal and social skills/resources and enhance adaptive coping 
strategies and protective factors (Dolbier et al., 2010). The overall aim of the training is that 
of increasing resilience by drawing on psychological approaches including cognitive 
behavioural therapy, rational-emotive therapy and family therapy (Dolbier et al., 2010).  
Increasingly, research emphasizes the importance of understanding patients’ illness 
perceptions in order to improve their psychosocial well-being (Cameron et al., 1998; Millar et 
al, 2005; Scharloo et al., 2005; Broadbent et al., 2009). Research shows that interventions 
(three sessions of approximately one hour) aimed at modifying illness perceptions in other 
populations (e.g. myocardial infarction and diabetes) have been found to lead to better health-
related outcomes (for example improved rates of return to work and lower levels of distress)  
(Broadbent et al., 2009; Skinner et al., 2006; Chilcot & Moss-Morris, 2013; Petrie et al., 
2002). Interventions using cognitive-behavioural techniques have also been found to lead to 
improvements in participants’ illness perceptions of treatment control, reductions in 
perceptions of the negative emotional impact of the condition and reductions in stress levels 
in Systemic Lupus Erythematosus (Goodman et al., 2005). Additionally, interventions have 
been shown to change/improve illness perceptions related to timeline chronicity, severity of 
consequences and poor perceived control as well as improve physical symptomatology in 
patients who have experienced myocardial infarction (Petrie et al., 2002). 
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Assessment of illness perceptions can be carried out quickly and easily and can be helpful in 
providing guidance to health care planning and can potentially support the identification of 
patients at greater risk of negative psychosocial outcomes. Appropriate information about 
which symptoms and which consequences to expect seems important (Rozema et al., 2009) 
since satisfaction with information provided has been associated with better outcomes, 
including more positive illness perceptions in cancer patients (Iskandarsyah et al., 2013).  
Future research 
Stronger evidence is required to better understand changes in illness perceptions and 
resilience over time and at different stages of a patient’s illness trajectory. Qualitative and 
quantitative longitudinal studies are required to examine how changes in illness perceptions 
and resilience are related to changes in psychological distress and quality of life (by measures 
being completed at various time points) and in order to understand whether baseline resilience 
has a long-term impact on cancer survivors’ well-being. Additionally, qualitative studies 
exploring cancer survivors’ beliefs about what makes them more resilient would be useful in 
further understanding the concept of resilience in cancer patients and guiding future research 
in this area. Further research is required in order to replicate this study in other cancer types, 
in other treatment types, in patients with metastatic cancer and in patients receiving palliative 
care. It may be interesting to repeat the study also in specific cancer groups and/or treatment 
types in order to better understand the impact of illness perceptions and resilience on 
psychological well-being and QoL in more clearly defined groups. 
Studies using prospective and longitudinal designs are required in order to understand the 
temporal dimensions of the self-regulatory model across two or more points in time and in 
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order to identify further relationships between illness perceptions, psychological well-being 
and quality of life. 
Conclusions 
The present study supports previous research that suggests that resilience is an important 
predictor of quality of life and psychological well-being in cancer survivors. Furthermore, the 
results illustrate significant relationships between negative illness perceptions, poorer QoL 
and lower mood in cancer patients. Additionally, resilience was found to be associated with 
perceptions of cancer as being more controllable and less emotionally loaded. This research 
could have significant clinical implications; addressing negative illness perceptions and 
psychological resilience could be beneficial to cancer survivors. Further research is needed to 
confirm and expand on these findings in different cancer populations, at different stages of 
cancer (e.g. metastatic, palliative care) and at different stages of the cancer trajectory.
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This document provides an overview of the thesis submitted in partial fulfilment of the 
requirements for the degree of Doctorate of Clinical Psychology (Clin.Psy.D.) at the 




Illness perceptions and psychological well-being in female cancer patients. A systematic 
review.  
 
Background: Cancer is among the leading causes of death worldwide. Improvements in the 
detection and better treatments have led to a rise in the number of people affected by cancer 
(DeSantis et al., 2014) and the rates of cancer survivors are increasing each year (Maddams et 
al., 2008). A diagnosis of cancer has a large impact on a number of areas of a woman’s life 
including mental health, quality of life, relationships and employment. Research in female 
cancer patients shows that to support cancer patients’ well-being it is important to understand 
patients’ beliefs about their illness and the way in which they cope with their illness 
(Cameron et al., 2005; Scharloo et al., 2005). To do this we can draw on health psychology 
models. One such model is Leventhal’s Common Sense model (CSM). According to this 
model, when a person is faced with a health threat, they create beliefs about their illness, 
which enable them to make sense of their symptoms and guide any coping actions (Hale et al., 
2007). These in turn have an impact on the person’s well-being (Leventhal et al., 2005). 
Aim: The aim of this literature review was to understand how women’s beliefs about their 
cancer impact on their well-being (e.g. mental well-being, relationships, ways of coping and 
quality of life).  
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Method: A systematic search was undertaken to identify studies that looked at women’s 
beliefs (perceptions) about their illness (cancer). After screening, 16 studies were chosen to be 
included in the review. Relevant data about each study (e.g. study design, type of 
questionnaire used to measure the illness perceptions, type of cancer) were extracted, and the 
quality of each study was also assessed. 
Findings: The review found that there are some types of beliefs people hold about their 
illness (related to the identity, cause, control, consequences and timeline of the illness) that 
are more frequently studied compared to other types of beliefs (e.g. coherence and emotional 
representations of the illness). There are also some aspects of women’s well-being that are 
more frequently studied (e.g. psychological distress). 
The review found that more positive beliefs about the identity of the illness, the timeline of 
the illness, the consequence of the illness, the causes of the illness and control beliefs about 
the illness were related to greater psychological well-being. The results of the review were 
difficult to generalise due to little overlap between the various aspects of well-being and types 
of illness perceptions looked at across studies. 
Conclusions: Different types of well-being (psychological distress, coping, quality of life, 
social and emotional support and changes in health practices) were found to be related to one 
or more types of illness perceptions in women with cancer. Given the complexity of the 
overall picture, comparison across studies was challenging. Further research is needed to 
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Illness perceptions, resilience and psychological well-being in cancer survivors 
 
Background: Over 331,000 people were diagnosed with cancer in 2011 in the UK (Cancer 
Research UK, 2014). Improvements in the detection and better treatments have led to a rise in 
the number of people affected by cancer (DeSantis et al., 2014) and the rates of cancer 
survivors are increasing each year (Maddams et al., 2008). A diagnosis of cancer has a large 
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impact on a number of areas of a person’s life including mental health, quality of life, 
relationships and employment. The NHS Cancer Reform Strategy (Department of Health, 
2007) stresses the importance of social and psychological support for cancer survivors in 
order to resume ‘as normal a life as they can’. Some people experience higher levels of 
distress than others (Moskowitz, 2010). Resilience, the process of effectively negotiating, 
adapting to, or managing significant sources of stress or trauma (Windle, 2011) can be seen as 
a protective factor against distress (Sharpley et al., 2014; Ryu & Yi, 2013; Min et al., 2013; 
Luthar & Cicchetti 2000). Additionally, research shows that to support cancer patients’ well-
being it is important to understand their beliefs about their illness (Cameron et al., 2005; 
Scharloo et al., 2005). When a person is faced with a health threat, they create beliefs about 
their illness (also called illness perceptions, cognitive representations or schema), which 
enable them to make sense of their symptoms and guide any coping actions (Hale et al., 
2007). These in turn have an impact on the person’s well-being (Leventhal et al., 2005). 
Aim: The current study explored the relationship between cancer patients’ beliefs about their 
illness, their resilience and mental well-being. 
Method: Cancer patients who had received cancer treatment within the previous eight months 
were asked to complete questionnaires including questions around their illness perceptions, 
resilience, quality of life and mental well-being.  
Findings: Data from two hundred and forty-seven cancer survivors (135 male, 112 female) 
were included in the study. The results showed that cancer patients’ resilience was important 
in relation to their psychological well-being and better quality of life following cancer 
treatment. The findings also showed that more positive beliefs about the consequences of the 
illness and more positive beliefs in treatment control were related to better psychological 
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well-being and greater quality of life. Furthermore, patients’ emotional responses to having 
cancer (emotional representations) were also significantly related to mental well-being 
(positive emotional responses predicted a greater psychological well-being). 
Conclusions: Results support previous findings that suggest that resilience is related to 
quality of life and psychological well-being in cancer patients. Significant relationships were 
found between negative illness perceptions, poor quality of life and low mood. Cancer 
patients may benefit from psychological support to address negative beliefs about their illness 
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Hierarchical multiple regression analysis for the predictors of quality of life (Global Health Scale) in 















β in final 
equation 
 
1. Demographic and clinical factors 
    Age 
    Surgery 
    Chemotherapy  













2. Self-regulation model 
    Consequences 
    Emotional representations 
    Timeline 
    Treatment control 
    Coherence 
    Personal control 







3. Resilience .221 .111 2.01 .46** 




Hierarchical multiple regression analysis for the predictors of psychosymptomatology (Global Symptom 















β in final 
equation 
 
1. Demographic and clinical factors 
    Age 
    Surgery 
    Chemotherapy  













2. Self-regulation model 
    Consequences 
    Emotional representations 
    Timeline 
    Treatment control 
    Coherence 
    Personal control 







3. Resilience .276 .170* 2.59 -.37* 
*p<.01; ** p<.001. 
 
 




















β in final 
equation 
 
1. Demographic and clinical factors 
    Age 
    Surgery 
    Chemotherapy  













2. Self-regulation model 
    Consequences 
    Emotional representations 
    Timeline 
    Treatment control 
    Coherence 
    Personal control 







3. Resilience .338 .237* 3.343 .079 




















β in final 
equation 
 
1. Demographic and clinical factors 
    Age 
    Surgery 
    Chemotherapy  













2. Self-regulation model 
    Consequences 
    Emotional representations 
    Timeline 
    Treatment control 
    Coherence 
    Personal control 







3. Resilience .246 .127 2.074 -.24 
*p<.01; ** p<.001. 
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Appendix G - Questionnaire 
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Appendix H - Author Guidelines for Psycho-Oncology 
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